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Abstract 
Aboriginal peoples are at a higher risk of many chronic respiratory diseases compared 
to the general Canadian population. Gender differences in incidence, susceptibility and severity 
of chronic respiratory diseases have also been long recognized among Aboriginal Peoples. 
Patients with Asthma-COPD Overlap (ACO), a disease newly described in 2015, are associated 
with frequent exacerbations, rapid decline in lung function, poor quality of life, high mortality 
and disproportionate utilization of healthcare resources than patients with asthma and COPD 
alone. The aim of this analysis is to investigate the prevalence and risk factors of ACO in 
Aboriginal peoples and to assess their gender-specific risk factors.  
The Aboriginal Peoples Survey 2012 (N=28,410) is the fourth cycle of a national cross-
sectional survey representative of the First Nations living off reserve, Metis and Inuit. The 
ACO definition was based on the respondent giving positive responses to both of the following 
questions “Do you/Does(name) have Asthma diagnosed by a health professional?” and “Do 
you/Does (name) have chronic bronchitis, emphysema or chronic pulmonary obstructive 
disease or COPD diagnosed by a health professional?”  
The prevalence of ACO was 1.65% and 3.53% in Aboriginal males and females 
respectively. Aboriginal peoples older than 45 years, having a total personal income below 
$20,000 were associated with a significant risk of ACO. Residing in Ontario and Quebec, living 
in a rented dwelling, dwelling in need of major repairs and working more than 40 hrs a week 
were also significantly associated with increased risk of ACO while female-specific risk factors 
significantly associated with increased risk of ACO included being widowed, separated or 
divorced, a current daily smoker and having a diagnosis of diabetes. The results from this study 
will offer useful evidence for future development of prevention and public health intervention 
programs in Aboriginal communities to reduce the burden of ACO. 
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CHAPTER 1 
INTRODUCTION 
1.1 Asthma-COPD Overlap (ACO) 
Asthma-COPD Overlap (ACO) is clinically characterized by persistent airflow limitation 
with several features usually associated with asthma and several features usually associated 
with Chronic Obstructive Pulmonary Disease (COPD).1,2 ACO is therefore identified by the 
features that it shares with both asthma and COPD. This is a new obstructive lung disease with 
its first treatment and management guidelines reported in 2015.1 
1.2 Diagnosis of ACO 
ACO is a disease that affects patients above 40 years of age but may have had symptoms 
in childhood or early adulthood. This is similar to patients with COPD who are usually 
diagnosed around the same age.3,4 Patients with ACO report a history of physician-diagnosed 
asthma which could be current or previous, allergies, family history of asthma and exposure to 
noxious gases.2-4 Respiratory symptoms for ACO may include persistent exertional dyspnea 
but variability may be prominent while asthma may be triggered by exercise, emotions, dust or 
exposure to allergens.5-7 COPD is quite similar to ACO with continuous symptoms particular 
during exercise. Patients with ACO present with worse exacerbations compared to asthma and 
COPD which can be reduced considerably by treatment.5,8 The presence of comorbidities is 
also common among patients with ACO which could also contribute significantly to 
impairment. Chest X-ray scans of patients with COPD are similar to those with ACO which 
include severe hyperinflation.  
1.3 Survey Questionnaires 
The use of questionnaires for assessing obstructive airway diseases (OADs) have been 
in practice for a long time. The first widely used questionnaire in respiratory epidemiology was 
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the Medical Research Council (MRC) of Great Britain. In the first version, from 1960, there 
were only a few questions about wheezing, but in later editions, more questions about asthma, 
Chronic Bronchitis (CB), which is a type of COPD and asthma-like symptoms were added.9,10 
The MRC questionnaire initiated the development of other questionnaires such as the European 
Community for Coal and Steel (ECSC) questionnaire of respiratory symptoms and the 
questionnaire from the American Thoracic Society and the Division of Lung Diseases (ATS-
DLD-78).10 In the 1960 version of the MRC questionnaire, there were only a few questions 
about wheezing and unspecified chest illnesses. In the 1966 version, this topic was expanded 
with questions about attacks of shortness of breath and wheezing. A specific question on 
bronchial asthma was also added. In the 1986 version, the questions about wheeze and episodic 
breathlessness also dealt with the occurrence within the last 12 months.9-11  
In more recent years, large population-based surveys, often rely on questionnaires as 
they are relatively economical when compared to examination of each subject.12,13 The 
Tasmanian Asthma Survey (TAS) and the International Study of Asthma and Allergies in 
Childhood (ISAAC) are more recent questionnaires to measure the prevalence of asthma in 
adults and children.14 These two questionnaires showed high agreement with respiratory 
physician diagnosis with respect to asthma symptoms in the past 12 months. For the TAS 
questionnaire the positive and negative predictive values for physician diagnosis for adults 
were 0.89 and 0.94 respectively. The instrument was also sensitive 0.80 (0.58-0.93) and highly 
specific 0.97 (0.90-0.99).12 
1.4 Aboriginal Peoples Survey 2012 (APS) 
The APS 2012 is a national cross-sectional survey data collected by Statistics Canada 
from February to July 2012. This is the fourth cycle representative of the First Nations living 
off reserve, Metis and Inuit. The APS 2012 was reported to have a response rate of 76% and 
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respondents were chosen based on self-identification as being Aboriginal or having Aboriginal 
ancestry from the 2011 National Health Survey (NHS).  It collected detailed information on 
Aboriginal identity, education, culture, income, health status, housing and family background. 
This study included only Aboriginal peoples aged ≥12 years to whom the information on the 
diagnosis of ACO was collected. A total of 28,410 Aboriginal peoples in the APS provide 
sufficient power for our statistical analysis 
1.5 Outcome Variable  
The outcome variable for this thesis, as mentioned earlier is ACO. This is a new disease 
described in 2015 and identified by the features that it shares with both asthma and COPD. The 
primary outcome variable ACO was based on the respondent giving positive responses to both 
of the following questions “Do you/Does(name) have Asthma diagnosed by a health 
professional?” and “Do you/Does (name) have chronic bronchitis, emphysema or chronic 
pulmonary obstructive disease or COPD diagnosed by a health professional?”. 
 
1.6 Predictor Variables 
The predictor variables selected for this thesis were based on literature review on the 
risk factors associated with asthma and COPD15,16 and also the availability of variables in the 
survey data. We assessed the questions asked in the survey codebook putting into consideration 
missing values and valid answers to several questions. Several epidemiological studies show 
that demographic variables of Age, Sex and Marital Status have a significant association with 
OADs.5,17,18 Environmental variables which include rural or urban, province, dwellings in need 
repairs, number of people in a household and number of rooms in a dwelling have also been 
associated with asthma, COPD and ACO.19-21 In addition, socio-economic variables such as 
total personal income, number of paid hours per week and dwelling whether owned or rented 
have been reported to be associated with OADs.22-24 Also, lifestyle variables which includes 
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smoking status and smoking in the home have been reported to be associated with COPD.25 
We considered a number of diseases in the APS survey data, however we either could not prove 
the relationship with respiratory diseases in the literature review or the variables had high 
missing values. Diabetes was the only disease that can be linked to respiratory diseases and 
also had a good number of values for analysis.26-28 
1.7 Statement of the problem 
Aboriginal peoples are at a higher risk of many chronic respiratory diseases compared 
to the general Canadian population.29-31 A recent Canadian survey showed that approximately 
15% of Aboriginal peoples had been diagnosed with at least one of the chronic respiratory 
diseases (COPD, CB, emphysema and asthma) compared to 10% for non-Aboriginal peoples 
in Canada.32 Inequalities in health status often result from social, cultural, economic, 
environmental and political factors. Education level, occupation, income, rurality, accessibility 
to health care and possible interplays between these determinants of health can lead to 
disparities. A higher prevalence of chronic respiratory diseases in Aboriginal peoples has been 
associated with many factors including higher smoking rate, poor housing, poor schooling, low 
household income and lack of timely access to health care.33  
OADs including asthma and COPD have been associated with social, economic and 
health impact on individuals, families and society in general.34 In a US study, the prevalence 
of adult asthma was reported to be 7.7% in those aged 35-64 years, while the prevalence of 
COPD was between 6.6% to 9.2% across the age group of 45 to 64 years; and even higher from 
11.6% to 12.1% across age 65 years and older.35,36 Recently, a new obstructive airway disease, 
Asthma-COPD Overlap (ACO) was described, with its first treatment and management 
guidelines reported in 2015.37 Patients with ACO experience a greater health burden including 
worse respiratory symptoms, poorer health-related quality of life (QOL), frequent 
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exacerbations leading to more emergency visits, comorbidities and higher doses of 
medications, as compared to asthma and COPD alone.34,38-40 
Several studies on the incidence of ACO in the general population have been carried 
out in the US, UK, Poland, Finland, Spain and Latin American countries.2,27,34 A recent study 
from Finland suggested that the prevalence of ACO was about 27% in asthma patients with a 
smoking history.41 Another study suggested that about 10 to 20% of patients with COPD may 
have ACO.2 A retrospective study reported that patients with ACO had a significantly higher 
prevalence of comorbidities, greater health care utilization rates and nearly doubled health care 
costs.38 Another retrospective cohort also reported higher hospitalization rates in patients with 
ACO compared to the patients with COPD only (31.3% vs 13%, P = 0.0001).42However, there 
remains a gap in knowledge about the burden and risk factors of ACO in Aboriginal peoples.  
Sex and gender differences in incidence, susceptibility and severity of many chronic 
respiratory diseases have been long recognized. Females generally experience more severe 
symptoms and a worse prognosis for asthma compared to males of the same age,43; while males 
are at higher risk for COPD than females.44 Although the biological mechanisms of sex 
differences are not fully understood, recent evidence suggests the involvement of sex-related 
hormones. Epidemiological studies consistently show differences in many lung diseases before 
and after both puberty and menopause when sex hormones experience dramatic changes.45-47 
Macsali et al, 2012. observed that women who underwent early puberty had a lower lung 
function and more asthma in adulthood. Varying levels of the female sex hormones (oestrogen 
and progesterone) during the regular, pregnancy and late ovulatory cycles play a key role in 
chronic respiratory diseases.48 Increased asthma exacerbation and lung functions changes have 
been reported during pregnancy and menstrual cycle phases respectively.49-51 
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Results from these studies have suggested that sex hormones play a significant role in 
many chronic lung diseases. Recent epidemiological studies consistently show that gender 
differences significantly affect the risk of lung diseases. Females in rural areas exposed to high 
levels of biomass smoke and other indoor air pollutants due to routine cooking are associated 
with higher levels of respiratory diseases compared to males, and about 50% of deaths in 
females were associated with COPD.52Another study reported that due to the recent increased 
rate of cigarette smoking among women, they may be more disposed to the development of 
severe COPD.53 
1.8 Study objectives 
The primary objective of this study is to investigate the prevalence and risk factors of 
this new disease ACO in Aboriginal people. The secondary objective is to assess the gender-
specific risk factors associated with ACO in Aboriginal people. Data from the 2012 Aboriginal 
Peoples Survey (APS), a national survey with detailed information on the demographics, 
environmental, health and lifestyle status of Aboriginal people provided a unique platform to 
address these questions. 
1.9 Thesis submitted for the partial fulfilment of MSc 
This thesis consists of a comprehensive literature review on Aboriginal peoples, the 
prevalence of Asthma and COPD, Asthma COPD Overlap (ACO). It is followed by two studies 
designed to address each of the two specific objectives. 
 In Chapter 2, a detailed description of the prevalence and risk factors of ACO in 
Aboriginal people. 
 In Chapter 3, gender-specific risk factors associated with ACO in Aboriginal People 
were assessed. 
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 A summary of the results of the two studies earlier mentioned is presented in Chapter 
4. This chapter includes an overview of the thesis research, specific risk factors and gender 
specific risk factors associated with ACO in Aboriginal people, strength and limitations of the 
studies and plans for future research. 
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CHAPTER 2 
PREVALENCE AND RISK FACTORS OF ACO (ASTHMA COPD OVERLAP) IN 
ABORIGINAL PEOPLE 
2.1 ABSTRACT 
Aboriginal peoples are at a higher risk of many chronic respiratory diseases compared 
to the general Canadian population. Patients with Asthma-COPD Overlap (ACO), a disease 
newly described in 2015, are associated with frequent exacerbations, rapid decline in lung 
function, poor quality of life, high mortality and disproportionate utilization of healthcare 
resources than patients with asthma and COPD alone. The objective was to investigate the 
prevalence and risk factors of ACO in Aboriginal peoples. Data from the 2012 Aboriginal 
Peoples Survey (APS) was used for this study. The ACO definition was based on the 
respondent giving positive responses to both of the following questions “Do you/Does(name) 
have Asthma diagnosed by a health professional?” and “Do you/Does (name) have chronic 
bronchitis, emphysema or chronic pulmonary obstructive disease or COPD diagnosed by a 
health professional?”. Aboriginal peoples older than 45 years, female, widowed, separated or 
divorced, having a total personal income below $20,000 were associated with a significant risk 
of ACO. Residing in Ontario, being a daily smoker, living in a rented dwelling, dwelling in 
need of major repairs, having diabetes and working more than 40 hrs a week were also 
significantly associated with increased risk of ACO. The results from this study will provide 
information to aid the development of prevention and intervention strategies for Aboriginal 
communities. 
This manuscript has been published on the Journal of Environmental and Public Health. “Prevalence and Risk Factors of 
ACO (Asthma COPD Overlap) in Aboriginal People. Adetola Koleade AK, Dr. Jamie Farrell JF, Dr. Gerald Mugford GM, 
Dr. Zhiwei Gao ZG”. AK: Literature Review, Manuscript Preparation, Data Analysis and Thesis write-up, JF: Manuscript 
Preparation, GM: Manuscript Preparation, ZG: Manuscript Preparation, Data Analysis  
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2.2 Introduction 
Aboriginal peoples are at a higher risk of many chronic respiratory diseases compared 
to the general Canadian population.1-3 A recent Canadian survey showed that approximately 
15% of Aboriginal peoples had been diagnosed with at least one of the chronic respiratory 
diseases (chronic obstructive pulmonary disease [COPD], chronic bronchitis (CB), emphysema 
and asthma) compared to 10% for non-Aboriginal peoples in Canada.4 Inequalities in health 
status often result from social, cultural, economic, environmental and political factors. 
Education level, occupation, income, rurality, accessibility to health care and possible 
interplays between these determinants of health can lead to disparities. A higher prevalence of 
chronic respiratory diseases in Aboriginal peoples has been associated with many factors 
including higher smoking rate, poor housing, poor schooling, low household income and lack 
of timely access to health care.5 
Obstructive airway diseases including Asthma and COPD have been associated with 
social, economic and health impact on individuals, families and society in general.6 In a US 
study, the prevalence of adult asthma was reported to be 7.7% in those aged 35-64 years, while 
the prevalence of COPD was between 6.6% to 9.2% across the age group of 45 to 64 years; 
and even higher from 11.6% to 12.1% across age 65 years and older.7,8 Recently, a new 
obstructive airway disease, the Asthma-COPD Overlap (ACO) was described, with its first 
treatment and management guidelines reported in 2015.9 However, little information is 
currently available including the prevalence of ACO and its associated risk factors. A recent 
study from Finland suggested that the prevalence of ACO was about 27% in asthma patients 
with a smoking history.10 Another study suggested that about 10 to 20% of patients with COPD 
may have ACO.11 
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Patients with ACO experience a greater health burden including worse respiratory 
symptoms, poorer health-related quality of life (QOL), frequent exacerbations leading to more 
emergency visits, comorbidities and higher doses of medications, as compared to asthma and 
COPD alone.6,12-14 Given that aboriginal peoples are at a higher risk of chronic respiratory 
diseases,1,2,15 there is a need to study the prevalence and risk factors of this new disease (ACO) 
in Aboriginal people. Data from the 2012 Aboriginal Peoples Survey (APS), a national survey 
with detailed information on the demographics, environmental, health and lifestyle status of 
Aboriginal peoples provided a unique platform to address these questions. 
2.3 Methods 
2.3.1 Study design:  
Data from the 2012 APS collected by Statistics Canada from February to July 2012 was 
used for this study. This is a national cross-sectional survey of First Nations living off reserve, 
Metis and Inuit. It collected detailed information on Aboriginal identity, education, culture, 
income, health status, housing and family background. The APS 2012 was reported to have a 
response rate of 76%. Respondents were chosen based on self-identification as being 
Aboriginal or having Aboriginal ancestry from the 2011 National Health Survey (NHS). This 
study included only Aboriginal peoples aged ≥12 years to whom the information on the 
diagnosis of COPD was collected. 
2.3.2 Outcome variable and risk factors: 
The primary outcome variable ACO was based on the respondent giving positive 
responses to both of the following questions “Do you/Does(name) have Asthma diagnosed by 
a health professional?” and “Do you/Does (name) have chronic bronchitis, emphysema or 
chronic pulmonary obstructive disease or COPD diagnosed by a health professional?”. 
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The variables of interest were categorized into demographics, environmental, 
socioeconomic, lifestyle variables and other diseases. Demographic variables consist of Age, 
Sex and Marital Status; Environmental variables consist of Rural or Urban (This is defined by 
the NHS Population Centre size), Province, Dwelling - owned or rented, Dwelling – need 
repairs, Number of people in a household/Number of rooms in a dwelling. Socio-economic 
variables consisted of Total Personal Income, Employment – the number of paid hours per 
week. Lifestyle variables consisted of Smoking Status and Anybody smoking in the dwelling 
and other diseases such as Diabetes. The ethics approval for this study has been approved by 
the Health Research Ethics Board (HREB) of Newfoundland and Labrador with reference 
protocol number: 20171751. 
2.4 Statistical analysis:  
Mean (standard deviation), and count (frequency) was calculated for continuous and 
categorical variables, respectively.  Sampling weights were included in all statistical analyses. 
PROC SURVEYLOGISTIC was used to identify the significant risk factors for ACO in the 
univariate and multivariate analysis. Only clinically important factors and variables with a p-
value lower than 0.20 in the univariate analysis were included in the multivariate analysis. To 
account for complex survey design of the APS, variances were estimated using 1,000 bootstrap 
weights with a Fay adjustment factor of 0.75. The level of significance α=0.05 was used for 
the multivariate logistic regression. Data analysis was conducted using SAS version 9.4. 
2.5 Results 
2.5.1 Descriptive statistics: 
The distribution of the population is shown in Table 1. The prevalence of ACO in the 
Aboriginal population was (2.7%).  
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Examinations of demographic variables showed that almost half the population was 
between the age of 12 to 34 years (45%) followed by those aged 35 to 44 years (17%), 45 to 
54 years (18%), 55 to 64 years (12%) and 65 years and over (8%). Fifty-four percent of the 
sample were females. Married and Living in common-law represented the highest proportion 
of (48%) followed closely by Single and never married (38%) while the Widowed, separated 
and divorced group was (14%).  
Examination of environmental variables showed that individuals from a Large urban 
population centre (100,000 or more) represented the highest proportion (43%), followed by 
Rural area which was (24%), Small population centre (1,000 to 29,999) was (21%) while the 
Medium population centre (30,000 to 99,999) had the least at 12%. Individuals by province 
showed that Prairies (Alberta, Manitoba, Saskatchewan) had the highest proportion (36%), 
followed by Ontario (25%), British Columbia (17%), Quebec (10%), Atlantic Canada (Nova 
Scotia, Newfoundland and Labrador, Prince Edward Island and New Brunswick) (8%) while 
the Territories (Nunavut, Yukon, Northwest Territories) (4%). Dwellings that needed only 
regular maintenance recorded the highest proportion (62%) while dwellings that required 
major repairs yielded a proportion of (12%). Most people living in a dwelling of 3 to 5 rooms 
yielded (45%), 6 to 8 rooms recorded (33%), 9 rooms and over recorded (16%) while the least 
proportion was 0 to 2 rooms with (6%). 
Examination of social-economic status showed that individuals who earn $20,000 to 
49,999 per year had the highest proportion (32%), followed by those that earn between $5,000 
to 19,999 (28%). Individuals earning $50,000 to $100,000 and over were (23%) while the 
lowest proportion was $5,000 or less with (18%). About employment hours per week, 
individuals working above 80 hours and above recorded the highest proportion (46%), 21 to 
40 hours (37%), 41 to 79 hours per week and working part-time of 0 to 20 hours yielded (9%) 
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and (8%) respectively. Individuals that Owned a dwelling had a higher proportion (58%) when 
compared to those that Rent a dwelling (42%).   
Examination of lifestyle variables showed that individuals that smoked Daily had a 
proportion of (28%) while those that smoked Occasionally recorded a lower proportion (9%). 
Individuals that Smoke at home recorded a proportion of (64%) when compared to those that 
do not smoke at home (36%). Diabetes (type 1 and 2) was reported to be (9%) of the 
respondents. 
2.5.2 Univariate Analysis 
The results from the Univariate analysis are shown in Table 2. Age was significantly 
associated with ACO. In comparison to those aged 12-34 years, individuals who were older 
than 45 years were about three times more likely to have ACO (OR45 to 54 years = 2.81; 95% CI 
= 1.71 - 4.61, p <0.0001; OR55 to 64 years = 2.80; 95% CI = 1.71 - 4.59, p <0.0001) and (OR65 years 
and over = 3.20; 95% CI = 1.89 - 5.43, p <0.0001). Females were two times more likely to be 
associated with ACO than Males (OR = 2.18; 95% CI = 1.58 - 3.00, p <0.0001). In comparison 
to those Married or Living in common-law, individuals who were Widowed, Separated and 
Divorced (OR = 3.80; 95% CI = 2.48 - 5.84, p <0.0001) and Single and never married (OR = 
1.42; 95% CI = 1.01 - 2.00, p <0.0001) were more likely to be associated with higher risks of 
ACO.  
Individuals from the Small population centre were significantly less likely to be 
associated with ACO in comparison to individuals from a Large urban population centre (OR 
= 0.66; 95% CI = 0.45 - 0.98, p <0.0370). In comparison to Ontario, other provinces and regions 
were significantly less likely to be associated with ACO except for Quebec, (ORQuebec = 1.72; 
95% CI = 1.05 – 2.81, p <0.0320), (ORAtlantic = 0.32; 95% CI = 0.18 – 0.59, p <0.0002), 
(ORPrairies = 0.65; 95% CI = 0.42 – 1.00, p <0.0471), (ORBritish Columbia = 0.52; 95% CI = 0.32 – 
0.86, p <0.0100), (ORTerritories = 0.29; 95% CI = 0.17 - 0.51, p <.0001). Individuals residing in 
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a dwelling in need of major repairs were three times more likely to be associated with ACO 
compared to those that reside in a dwelling that needs only regular maintenance. (OR = 3.35; 
95% CI = 2.19 - 5.13, p <0.0001). In comparison to those living in a dwelling of 0 to 2 rooms, 
individuals living in a dwelling with 6 – 8 rooms and 9 rooms – over were significantly less 
likely to be associated with ACO, (OR6 – 8 rooms = 0.32; 95% CI = 0.16 - 0.63, p <0.0010), (OR9 
rooms + = 0.21; 95% CI = 0.10 - 0.44, p <0.0001). 
Among the socioeconomic variables, individuals who earn between $5,000 or less to 
$100,000 and over were significantly less likely to be associated with ACO in comparison to 
individuals who earn $5,000 to 19,999 (OR$5,000 or less = 0.35; 95% CI = 0.22 – 0.55, p <0.0001), 
(OR$20,000 to $49,999 = 0.36; 95% CI = 0.25 – 0.53, p <0.0001), (OR$50,000 to $100,000 and over = 0.13; 
95% CI = 0.07 – 0.24, p <0.0001). Individuals who worked 80 hours and over were 
approximately four times more likely to be associated with increased risk for ACO when 
compared to 0 to 20 hours of paid hours per week. (OR = 3.65; 95% CI = 1.82 - 7.32, p = 
0.0003). Also, individuals living in the rented dwelling were three times more likely to be 
associated with ACO when compared to those owning the dwelling (OR = 2.69; 95% CI = 1.95 
- 3.70, p <0.0001). 
Among lifestyle variables, Daily smoking was more than two times more likely to be 
associated with ACO in comparison to individuals reporting No smoking at all (OR = 2.42; 
95% CI = 1.78 - 3.32, p <0.0001). Furthermore, individuals with a report of smoking at home 
were two times more likely to be associated with ACO when compared to those with report 
Not smoking at home (OR = 2.04; 95% CI = 1.42 - 2.94, p <0.0001).  
Individuals who report a diagnosis of Diabetes type 1 and 2 were three times more 
likely to be associated with ACO compared to those without the diagnosis of diabetes (OR = 
3.38; 95% CI = 2.34 - 4.90, p <0.0001). 
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2.5.3 Multivariate Analysis 
As shown in Table 3, the results from the multivariate analysis showed the following 
demographic variables were significantly associated with ACO: Individuals aged between 45 
to 54 years were two times more likely to be associated with ACO in comparison to individuals 
aged between 12-34 years (OR = 2.43; 95% CI = 1.34 - 4.42, p = 0.0035). Females were 
approximately two times more likely to be associated with ACO compared to Males (OR = 
1.74; 95% CI = 1.25 - 2.45, p = 0.0013) Also, individuals who were widowed, separated or 
divorced were two times more likely to be associated with ACO compared to individuals who 
were either married or living in common-law (OR = 1.97; 95% CI = 1.19 to 3.25, p = 0.0080).  
In comparison to individuals from Ontario, individuals from Atlantic regions, 
Territories and British Columbia were significantly less likely to be associated with ACO. 
(ORAtlantic Canada = 0.31; 95% CI = 0.16 to 0.61, p = 0.0007), (ORTerritories = 0.21; 95% CI = 0.21 
- 0.39, p = <0.0001) and (ORBritish Columbia = 0.51; 95% CI = 0.30 to 0.88, p = 0.0158). Also, 
individuals living in a dwelling in need of major repairs were two times more likely to be 
associated with ACO compared to those living in a dwelling in need of regular maintenance 
(OR = 2.31; 95% CI = 1.46 - 3.65, p = 0.0004).  
Among the socioeconomic variables, the following three variables were significantly 
associated with ACO: Individuals who earn between $5,000 to $19,999 were three times more 
likely to be associated with ACO compared to those who earn $50,000 to $100,000 and over. 
(OR = 3.00; 95% CI = 1.44 to 6.23, p = 0.0033). Individuals working long hours of 41 to 80 
hours and 81 hours and over were significantly associated with ACO compared to those 
working 0 to 20 hours per week. (OR41 to 80 hours = 2.83; 95% CI = 1.12 to 7.14, p = 0.0273), 
(OR81 hours and over = 2.85; 95% CI = 1.36 to 5.97, p = 0.0057). Also, individuals who live in a 
rented dwelling were approximately two times more likely to be associated with ACO than 
those owning a dwelling (OR = 1.76; 95% CI = 1.24 to 2.51, p = 0.0018). 
23 | P a g e  
 
Smoking was significantly associated with ACO: individuals who smoke daily were 
found to be about two times more likely to be associated with ACO compared to those that do 
not smoke at all (OR = 1.66; 95% CI = 1.14 - 2.41, p = 0.0084). Aboriginal people with diabetes 
(type 1 and 2) were also approximately two times more likely to develop ACO compared to 
those without the diagnosis of diabetes (OR = 1.68; 95% CI = 1.10 to 2.58, p = 0.0188). 
 
2.6 Discussion 
Using the APS dataset, our results suggest that Aboriginal peoples older than 45 years, 
female, widowed, separated or divorced, having a total personal income below $20,000 were 
associated with a significant risk of ACO. Residing in Ontario, being a daily smoker, living in 
a rented dwelling, dwelling in need of major repairs, having diabetes and working more than 
40 hrs a week were also significantly associated with increased risk of ACO.  
Individuals aged 45 to 54 years old are two times more likely to be associated with 
ACO when compared to the younger individuals aged 12 to 34 years. In a longitudinal 
population-based study in the Netherlands, the authors reported that the risk of being diagnosed 
with COPD increased with age. A male who was free of COPD at age 40, had an increased risk 
of being diagnosed with COPD from 0.8% to 12% with increasing years from 10 to 40 years; 
while a female of the same age, had increased risk from 0.8% to 8.3%.16 In another population-
based cohort study from Ontario, Canada, estimating trends in the prevalence and incidence of 
concurrent physician-diagnosed asthma and COPD, the authors reported that the standardized 
prevalence increased by 10.5% from 2002 to 2012 mainly in young adults.17 Additionally, a 
cross-sectional study among Aboriginal people assessed the risk factors associated with COPD. 
It was reported that individuals aged 55 and older were significantly associated with the risk of 
COPD.18 We could find no other studies that focused on Aboriginal peoples with ACO. 
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Chronic respiratory diseases, especially COPD have always been attributed to men 
older than 40 years. However, recent findings suggest that there is a growing increase in women 
diagnosed with COPD. In a study of 1,633 residents from Saskatchewan, Canada, it was 
reported that in females, the combined effect of grain farming and smoking history had a 
significant association with CB but not in males.19  Another study assessing the prevalence of 
CB in Aboriginal peoples reported that females had a higher prevalence than males.4 
Additionally, females with more severe COPD have a higher risk of hospitalization and death 
due to respiratory failure and possible comorbidities when compared to males.20 Our study 
which appears to be the first to assess the risk of ACO in Aboriginal peoples, suggests that 
Aboriginal females are approximately two times more likely to report ACO compared to males.   
The association between obstructive airway diseases and marital status has been 
examined in many population studies. In a study, patients diagnosed with COPD were 
described and compared based on their nutritional status, gender, pulmonary function and 
marital status. The authors reported that individuals diagnosed with COPD who lived alone 
had a worse nutritional status.21 A longitudinal study in the US focused on the psychological 
imbalance caused by bereavement and divorce in relation to COPD. It was reported that 
remarriage after bereavement or divorce was associated with a significantly decreased risk of 
COPD onset.22 Our study showed that Widowed, Separated and Divorced Aboriginal peoples 
were found to be two times more likely to be associated with ACO compared to those married 
or living common-law. 
We reported significant geographic variation in the prevalence of ACO with people in 
Ontario being at a significantly higher risk of ACO compared to people from other provinces 
or regions. A study in Ontario, Canada, assessed individuals with asthma and COPD to see if 
higher levels of exposure to air pollution will increase the risk for ACO.23 The authors reported 
that individuals exposed to higher levels of air pollution had nearly three times the risk of 
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developing ACO.23 The same group of researchers in a longitudinal cohort of women reported 
that the risk of COPD increased by more than 20% with each unit increase in exposure to 
PM2.5.
24 The presence of industries and a huge population with automobiles Quebec and 
Ontario could play a role in the association between air pollution and ACO. The APS 2012 
survey focused on aboriginal people living off reserve which could be interpreted that certain 
parts of these two provinces inhabited by aboriginal people might experience air pollution.  
In our study, we reported that Aboriginal peoples living in dwellings in need of major 
repairs were two times more likely to develop ACO. A study examining the differences in 
hospitalization for respiratory tract infections among First Nations using the 2006 census 
reported that poor housing conditions and income were contributing factors in hospitalization.25 
Another study from Saskatchewan, Canada, which assessed the prevalence of CB in two 
Aboriginal communities, reported that houses with a musty smell of mould were positively 
associated with CB.26 This is also consistent with a study from the United States, which 
reported that 15% of people who reported a musty smell in their dwelling also reported CB and 
asthma.27  
 Meanwhile, studies have shown that lower socioeconomic status is associated with 
respiratory diseases.28,29 Total personal income and paid employment hours in our study 
suggested Aboriginal peoples working over 40 hours a week and earning a low annual income 
of $20,000 were more likely to develop ACO when compared to Aboriginal peoples earning 
an income of $50,000 or greater and working same or fewer hours. A large population-based 
study of 8, 028 individuals reported that low income and low quality of education were risk 
factors for asthma and COPD.29 In a cross-sectional study that focused on the associated factors 
of COPD among Aboriginal peoples, the authors reported that Aboriginal peoples making less 
than the median income of $20,600 were at a higher risk to be associated with COPD.18 
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There is still conflicting information about the impact of work hours on chronic 
respiratory diseases. A longitudinal study that continued for a 32-year period made use of the 
National Longitudinal Survey of Youth (NLSY) 1979. It collected information on job histories 
and work hours in relation to chronic disease status. The authors reported that there were no 
significant findings for an association between long hours and asthma.30 This was not 
consistent with the result of our study. This could be due to the homogeneity of the Aboriginal 
population used in our study compared to the general population used in this longitudinal study. 
In a study that focused on housing conditions, it was reported that homeownership was related 
to home quality.31 Poorly maintained houses could also lead to the loss of vapour barrier, which 
allows areas of dampness that are prone to contamination with mould.32 Owned dwellings tend 
to have their repairs fixed quicker than rented dwellings. Our results suggest that individuals 
renting a dwelling are also approximately three times more likely to develop ACO when 
compared to owning a house. 
In our study, individuals who smoke daily were found to be about two times more likely 
to be associated with ACO compared to those that do not smoke. Even though cigarette 
smoking has decreased considerably over the past decades, there is still a significant link 
between positive smoking or the exposure to environmental tobacco and respiratory 
diseases.10,33-35 Aboriginal peoples are observed to have higher smoking rates compared to the 
general Canadian population,5 but there are not many studies that have focused on the 
association between smoking and ACO. Kiljander et al. investigated the prevalence of ACO 
among 190 asthmatic patients with a smoking history. These patients had no previous diagnosis 
of COPD but were either current or ex-smokers with a history of at least ten pack years. It was 
reported that 27% of the patients were found to have ACO.10 Another study from Sweden 
examining the association between environmental tobacco smoke (ETS) and risk of COPD 
showed that ETS was independently associated with COPD. However, the association was 
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more significant with increased ETS exposure either at home, previous or current work or at 
the three mentioned locations.33 In two Aboriginal studies that investigated the factors 
associated with the prevalence of CB and COPD, daily or current smokers were significant 
compared to never smokers.4,18 
In our study, Aboriginal peoples a diagnosis of diabetes (either type 1 or type 2) were 
approximately two times more likely to develop ACO. Epidemiological studies have 
consistently reported that many socioeconomic and lifestyle factors such as smoking are 
significantly associated with both diabetes and chronic respiratory diseases.36,37 Pleasants et al, 
made use of the Behavioural Risk Factor Surveillance System (BRFSS) to assess the 
relationships between COPD, asthma and co-morbidities such as diabetes. It was reported that 
adults with overlap syndrome had the highest prevalence of diabetes.37 
In addition to the shared risk factors between chronic respiratory diseases and diabetes, 
the current medication for patients with asthma and COPD may also play a role. However, the 
results from different studies are not consistent. A nested case-control study from Quebec, 
Canada assessed whether the use and dose of inhaled corticosteroids increase the risk of 
diabetes onset and progression in patients treated for respiratory diseases. It was reported that 
current use of inhaled corticosteroids was associated with a 34% increase in diabetes onset and 
progression while risks were even more significant at higher doses for the treatment of COPD.38 
Another study from Poland reported that concomitant diseases were diagnosed in 85% of 
patients with ACO, with the prevalence of diabetes being approximately 20%.39 In contrast, a 
retrospective study evaluated whether there was an increased risk of new onset of diabetes or 
hyperglycemia among patients with asthma or COPD treated with inhaled corticosteroids. It 
was reported that treatment with inhaled corticosteroids in patients with asthma and COPD was 
not associated with increased risk of diabetes or hyperglycemia.40 
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As mentioned above, it was reported that aboriginal females are 1.74 times more likely 
to be associated with ACO than aboriginal males. However, the possible risk factors associated 
with the increased risk of ACO in aboriginal females are yet to be investigated. This lead us to 
the main research question of the 2nd manuscript (Chapter 3), which is to identify these risk 
factors. 
2.7 Limitations: 
There were several limitations to this study. The APS is a cross-sectional survey in 
which the information collected was gathered at a one-time period. This could lead to self-
reporting bias or misclassification.  Individuals self-reported the presence of asthma and COPD 
which lacks clinical accuracy. All other answers in this survey were also self-reported which 
could underestimate the prevalence of some variables. 
 
 
2.8 Conclusion 
To our knowledge, this is the first study to evaluate the prevalence and risk factors 
associated with ACO among Aboriginal peoples. Our study highlights the increasing 
prevalence of respiratory diseases in Aboriginal females. Even though ACO is a relatively new 
disease, our study still highlights the significance of smoking, dwelling in a house in need of 
major repairs; factors already known to be linked with respiratory diseases. Our study also 
highlights the association between ACO and concomitant diseases such as diabetes in 
Aboriginal peoples. There is a need to better understand the burden and risk factors of ACO in 
Aboriginal peoples. The findings from this study will provide information to health care 
workers, patients and their families, Indigenous governments/organizations and government 
agencies.  
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 2.1   Table of Descriptive Statistics 
Variables 
 
Labels % of the 
population 
Age 12 to 34  
35 to 44 
45 to 54 
55 to 64 
65 and over 
45% 
17% 
18% 
12% 
8% 
 
Sex Male  
Female 
46% 
54% 
Marital Status  Married and Living common-law  
Widowed, Separated and Divorced 
Single, never married  
48% 
14% 
38% 
Rural or Urban  Rural area  
Small population centre  
Medium population centre  
Large urban population centre  
 
24% 
21% 
12% 
43% 
Personal Income  $5000 or less income 
$5000 to $19,999         
$20,000 to 49,999 
$50,000 to $100,000 and over 
18% 
28% 
32% 
23% 
Province  Atlantic* 
Quebec 
Ontario 
Prairies 
British Columbia 
Territories** 
  
8% 
10% 
25% 
36% 
17% 
4% 
Smoking Status  Daily 
Occasionally 
Not at all 
 
28% 
9% 
63% 
Anybody smoking at 
home 
Yes 
No 
64% 
36% 
Dwelling 
(Owned/Rented)  
Owned  
Rented 
58% 
42% 
Dwelling in need of 
major repairs  
Yes, major repairs are needed 
Yes, minor repairs are needed 
No, only regular maintenance is 
needed 
 
12% 
26% 
62% 
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Diabetes  Diabetes type 1 and type 2 
Gestational and no diagnosis of 
diabetes 
 
9% 
91% 
How many rooms are 
there in a dwelling  
0 and 2 rooms 
3 and 5 rooms 
6 and 8 rooms 
9 rooms and over 
 
6% 
45% 
33% 
16% 
Number of paid hours 
per week  
0 to 20 hours 
21 to 40 hours  
41 to 79 hours 
80 hours and over 
8% 
37% 
9% 
46% 
 
 
 
*: including Nova Scotia, Newfoundland and Labrador, Prince   
     Edward Island and New Brunswick 
**: including Nunavut, Yukon, Northwest Territories 
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2.2    Table of Univariate analysis 
Variables Prevalence of ACO Odds ratio (95% CI) p-value 
Age 
       35 to 44 
       45 to 54 
       55 to 64 
       65 and over 
       12 to 34 
  
1.68 
4.31 
4.28 
4.88 
1.57 
 
 
1.07 (0.62 - 1.84) 
2.81 (1.71 - 4.61) 
2.80 (1.71 - 4.59) 
3.20 (1.89 - 5.43) 
1 
 
 
0.8045 
<0.0001 
<0.0001 
<0.0001 
Sex 
      Female 
      Male 
 
3.53 
1.65 
 
2.18 (1.58 - 3.00) 
1 
 
<0.0001 
Marital Status  
  Widowed, Separated and Divorced 
  Single, never married 
  Married and Living common-law 
 
 
  
6.76 
2.64  
1.87 
 
3.80 (2.48 - 5.84) 
1.42 (1.01 - 2.00) 
1 
 
 
<0.0001 
<0.0001 
Rural or Urban        
  Rural area 
  Small population centre 
  Medium population centre 
  Large urban population centre 
 
  
2.17 
2.00 
3.63 
3.00 
 
0.72 (0.48 - 1.06) 
0.66 (0.45 - 0.98) 
1.22 (0.74 - 2.00) 
1 
 
0.0953 
0.0370 
0.4346 
Personal Income 
  $5000 or less income 
  $20,000 to 49,999 
  $50,000 to $100,000 and over 
  $5000 to $19,999 
 
 
2.12 
2.18 
0.81 
5.85  
 
 
0.35 (0.22 – 0.55) 
0.36 (0.25 – 0.53) 
0.13 (0.07 – 0.24) 
1 
 
<.0001 
<.0001 
<.0001 
 
Province 
  Atlantic* 
  Quebec 
  Prairies 
  British Columbia 
  Territories** 
  Ontario 
 
1.11 
5.68  
2.23 
1.81 
1.01 
3.41 
 
 
0.32 (0.18 - 0.59) 
1.72 (1.05 - 2.81) 
0.65 (0.42 - 1.00) 
0.52 (0.32 - 0.86) 
0.29 (0.17 - 0.51) 
1 
 
 
 
 
0.0002 
0.0320 
0.0471 
0.0100 
<.0001 
Type of Smoker  
  Daily 
  Occasionally 
  Not at all  
 
 
4.47 
2.38 
1.89  
 
 
2.42 (1.78 - 3.32) 
1.26 (0.72 - 2.20) 
1 
 
<.0001 
0.4112 
Anybody smoking at home 
  Yes  
  No 
 
4.21  
2.38 
 
2.04 (1.42 - 2.94) 
1 
 
0.0001 
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Dwelling (Owned/Rented) 
  Rented 
  Owned 
 
4.12 
1.58 
 
2.69 (1.95 - 3.70) 
1 
 
<0.0001 
Dwelling in need of major repairs 
  Yes, major repairs are needed 
  Yes, minor repairs are needed 
  No, only regular maintenance is 
needed 
 
 
6.44 
2.47 
2.01 
 
 
3.35 (2.19 to 5.13) 
1.24 (0.86 to 1.78) 
1 
 
<0.0001 
0.2525 
Diabetes 
  Diabetes type 1 and type 2 
  Gestational and no diagnosis of 
diabetes 
 
 
7.20 
2.24 
 
 
3.38 (2.34 to 4.90) 
1 
 
<0.0001 
How many rooms are there in a 
dwelling 
  3 and 5 rooms 
  6 and 8 rooms 
  9 rooms and over 
  0 and 2 rooms 
 
  
 
3.70 
1.87 
1.23 
5.58 
 
 
 
0.65 (0.38 to 1.11) 
0.32 (0.16 to 0.63) 
0.21 (0.10 to 0.44) 
1 
 
 
0.1136 
0.0010 
<0.0001 
Number of paid hours per week 
  21 to 40 hours 
  41 to 80 hours 
  80 hours and over 
  0 to 20 hours 
 
  
1.22 
2.09 
4.21 
1.19 
 
 
1.03 (0.50 to 2.11) 
1.77 (0.75 to 4.17) 
3.65 (1.82 to 7.32) 
1 
 
 
0.9402 
0.1887 
0.0003 
*: including Nova Scotia, Newfoundland and Labrador, Prince Edward Island and New      
    Brunswick 
**: including Nunavut, Yukon, Northwest Territories 
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2.3    Table of Multivariate Analysis 
Variables Labels Odds ratio (95% CI) p-value 
Age 35 to 44 
45 to 54  
55 to 64 
65 and over 
12 to 34 
1.01 (0.54 to 1.87) 
2.43 (1.34 to 4.42) 
2.00 (0.97 to 4.09) 
1.68 (0.71 to 3.99) 
1 
 
0.9858 
0.0035 
0.0597 
0.2406 
Sex Female 
Male 
 
1.74 (1.25 to 2.45) 
1 
 
0.0013 
Marital Status Widowed, Separated and Divorced 
Single, never married 
Married and Living common-law 
1.97 (1.19 to 3.25) 
1.44 (0.94 to 2.20) 
1 
 
0.0080 
0.0908 
Personal Income $5000 or less income  
$5000 to $19,999       
$20,000 to 49,999 
$50,000 to $100,000 and over 
1.59 (0.71 to 3.54) 
3.00 (1.44 to 6.23) 
1.80 (0.89 to 3.66) 
1 
0.2559 
0.0033 
0.1019 
 
Province Atlantic  
Quebec 
Prairies 
British Columbia 
Territories  
Ontario 
0.31 (0.16 to 0.61) 
1.58 (0.94 to 2.64) 
0.73 (0.47 to1.14) 
0.51 (0.30 to 0.88) 
0.21 (0.12 to 0.39) 
1 
0.0007 
0.0834 
0.1660 
0.0158 
<0.0001 
Type of Smoker Daily 
Occasionally 
Not at all  
1.66 (1.14 to 2.41) 
1.10 (0.52 to 2.00) 
1 
0.0084 
0.9896 
Dwelling 
(Owned/Rented) 
 
Rented 
Owned 
 
1.76 (1.24 to 2.51) 
1 
 
0.0018 
Dwelling in need 
of major repairs 
Yes, major repairs are needed 
Yes, minor repairs are needed 
No, only regular maintenance is needed 
2.31 (1.46 to 3.65) 
1.15 (0.79 to 1.69) 
1 
0.0004 
 
0.4579 
 
Diabetes Diabetes type 1 and type 2 
Gestational and no diagnosis of diabetes 
1.68 (1.10 to 2.58) 
1 
0.0188 
Number of paid 
hours per week 
21 to 40 hours 
41 to 80 hours 
80 hours and over 
0 to 20 hours 
 
1.16 (0.55 to 2.44) 
2.83 (1.12 to 7.14) 
2.85 (1.36 to 5.97) 
1 
 
 
 
0.7004 
0.0273 
0.0057 
*: including Nova Scotia, Newfoundland and Labrador, Prince Edward Island and New      
    Brunswick 
**: including Nunavut, Yukon, Northwest Territories 
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CHAPTER 3 
GENDER-SPECIFIC RISK FACTORS OF ACO (ASTHMA COPD OVERLAP) IN 
ABORIGINAL PEOPLE 
 
3.1 Abstract 
Gender differences in incidence, susceptibility and severity of many chronic respiratory 
diseases have been long recognized. Asthma-COPD Overlap (ACO), is a newly recognised 
disease with its management guidelines reported in 2015. The aim of this analysis is to assess 
the gender-specific risk factors associated with ACO in Aboriginal people. The Aboriginal 
Peoples Survey (APS) 2012 (N=28,410) is the fourth cycle of a national cross-sectional survey 
representative of the First Nations living off reserve, Metis and Inuit. The 2012 APS collected 
information on employment, education, health status, housing, family background and income. 
Survey Logistic Regression was used to identify the significant risk factors for ACO in the 
multivariate analysis. The prevalence of ACO was 1.65% and 3.53% in males and females 
respectively. The increased risk of ACO in both males and females was significantly associated 
with increased age, living in Quebec, longer hours of work per week, living in a rented dwelling 
and dwelling in need of major repairs while female-specific risk factors significantly associated 
with increased risk of ACO included being widowed, separated or divorced, a current daily 
smoker and having a diagnosis of diabetes. The results of our study will offer useful evidence 
for future development of prevention and public health intervention programs in aboriginal 
communities to reduce the burden of ACO. 
 
This manuscript has been submitted to the International Journal of COPD. “Gender-Specific Risk Factors of ACO (Asthma 
COPD Overlap) in Aboriginal People. Adetola Koleade AK, Dr. Jamie Farrell JF, Dr. Gerald Mugford GM, Dr. Zhiwei Gao 
ZG”. AK: Literature Review, Manuscript Preparation, Data Analysis and Thesis write-up, JF: Manuscript Preparation, GM: 
Manuscript Preparation, ZG: Manuscript Preparation, Data Analysis. 
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3.2 Introduction 
Asthma-COPD Overlap (ACO), is a newly recognised disease with its management 
guidelines reported in 2015.1 Several studies on the incidence of ACO in the general population 
have been carried out in the US, UK, Poland, Finland, Spain and Latin American countries.2-4 
Aboriginal people are at a higher risk of many chronic respiratory diseases.5,6 However, there 
remains a gap in knowledge about the burden and risk factors of ACO in Aboriginal peoples. 
Patients with ACO have a significantly higher prevalence of comorbidities, greater health care 
utilization rates and nearly doubled health care costs.7,8  
Sex and Gender differences in incidence, susceptibility and severity of many chronic 
respiratory diseases have been long recognized. Females generally experience more severe 
symptoms and a worse prognosis for asthma compared to males of the same age;9 while 
historically, males are at higher risk for COPD than females.10 Although the biological 
mechanisms of sex differences are not fully understood, recent evidence suggests the 
involvement of sex-related hormones. Epidemiological studies consistently show differences 
in many lung diseases before and after both puberty and menopause when sex hormones 
experience dramatic changes.11-13 
In addition to sex hormones, many epidemiological studies also report many 
environmental and lifestyle risk factors for chronic respiratory diseases including COPD. 
Females in rural areas exposed to high levels of biomass smoke and other indoor air pollutants 
due to routine cooking are associated with higher levels of respiratory diseases compared to 
males, and about 50% of deaths in females were associated with COPD.14 Another study 
reported that due to the recent increased rate of cigarette smoking among women, they may be 
more disposed to the development of severe COPD.15 The aim of this analysis is to assess the 
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gender-specific risk factors associated with ACO in Aboriginal people using data from the 
2012 Aboriginal Peoples Survey (APS). 
3.3 Methods 
3.3.1 Study design:  
The APS 2012 was collected by Statistics Canada from February to July 2012. This is 
the fourth cycle of a national cross-sectional survey representative of the First Nations living 
off reserve, Metis and Inuit. The APS 2012 was reported to have a response rate of 76%. 
Respondents were chosen based on self-identification as being Aboriginal or having Aboriginal 
ancestry from the 2011 National Health Survey (NHS). A total of 28,410 Aboriginal peoples 
in the APS provide sufficient power for our statistical analysis 
3.3.2 Outcome variable: 
The primary outcome variable ACO was based on the respondent giving positive 
responses to both of the following questions “Do you/Does(name) have Asthma diagnosed by 
a health professional?” and “Do you/Does (name) have chronic bronchitis, emphysema or 
chronic pulmonary obstructive disease or COPD diagnosed by a health professional?” 
3.3.3 Predictor Variables:  
Demographic variables consist of Age, Sex and Marital Status; Environmental variables 
include Rural or Urban (This is defined by the NHS Population Centre size), Province, 
Dwelling – need repairs, Number of people in a household/Number of rooms in a dwelling. 
Socio-economic variables consist of Total Personal Income, Employment – the number of paid 
hours per week and Dwelling - owned or rented. Lifestyle variables consisted of Smoking Status 
and Smoking in the home, and other diseases such as Diabetes. This ethics approval for this 
study has been approved by the Health Research Ethics Board (HREB) of Newfoundland and 
Labrador with reference protocol number: 20171751. 
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3.4 Statistical analysis:  
Data analysis was conducted using SAS version 9.4. Mean/SD and count/percent were 
used to summarize the study population. The differences in the continuous and categorical 
variables between males and females were examined by t-test and chi-square tests, 
respectively. Survey Logistic Regression was used to identify the significant risk factors for 
ACO in the univariate and multivariate analysis. Clinically important variables with p-
value<0.20 in the univariate analysis were included in the multivariate analysis. To identify 
gender-specific risk factors for ACO, the multivariate analysis was stratified into a male and 
female domain statement. Sampling weights were included in all statistical analyses. Variances 
were estimated using 1,000 bootstrap weights to account for complex survey design of the 
APS.  
3.5 Results 
3.5.1 Descriptive statistics: 
As shown in Table 1, female aboriginal people have a significantly higher prevalence 
of ACO than males (3.53% vs 1.65%, p <0.0001).  
Demographic variables represented by Age shows that there are no significant 
differences in the age distribution between males and females (47%) for males and (44%) for 
females (p = 0.3214). However, Marital Status shows a significantly higher proportion of males 
reporting Married and Living in common-law (51%) vs females (45%) (p <0.0001). 
Environmental variables shows a significant difference in proportion of people living 
in rural or urban between males and females (26% vs 23%, p = 0.0055). Individuals by 
province of residence did not show any significant differences. Females were also more likely 
to report living in Dwellings in need of major repairs (14% vs 9%, p <0.0001). On average, 
males live in a dwelling with more rooms than females (21% vs 18%, p = 0.0308). 
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Socio-economic variables highlight that males had a higher proportion of individuals 
earning $40,000 and over per year (32% vs 19%, p <0.0001). 49% of males were reported to 
work above 80 hours and above in comparison to 46% of females (p<0.0001). Males were less 
likely to live in Owned Dwellings than females, (40% vs 45%, p<0.0001). There were no 
significant differences in the distributions of Smoking status and Smoking at home between 
males and females.  
 
3.5.2 Univariate Analysis 
The results from the Univariate analysis are shown in Table 2. Age was significantly 
associated with ACO. Compared to males aged 12-34 years, males aged more than 45 years 
were more likely to be associated with ACO. (OR45 to 54 years = 2.21; OR55 to 64 years = 4.71; OR65 
years and over = 5.22). Similar associations were observed in females. In comparison to those 
Married or Living in common-law, Aboriginal males and females who were Widowed, 
Separated and Divorced were more likely to be associated with higher risks of ACO. (ORMales 
= 3.61; ORFemales = 3.36). 
Among males, in comparison to Aboriginal people living in Quebec, other provinces 
and regions of residence were significantly less likely to be associated with ACO (ORAtlantic and 
Territories = 0.17; OROntario = 0.38; ORPrairies = 0.29; ORBritish Columbia = 0.24). Similar associations 
were also observed in females. Aboriginal males and females residing in a dwelling in need of 
major repairs were three times more likely to be associated with ACO compared to those that 
reside in a dwelling that needs only regular maintenance. (ORMales = 2.56; ORFemales = 3.31). 
In comparison to those living in a dwelling with 0 to 5 rooms, males living in a dwelling with 
6 – 8 rooms were significantly less likely to be associated with ACO (OR6 – 8 rooms = 0.39) while 
females living in a dwelling with 6 – 8 rooms or 9 rooms and over were also significantly less 
likely to associated with ACO (OR6 – 8 rooms = 0.51; OR9 rooms + = 0.19). 
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Among the socio-economic variables, males with annual income between $5,000 to 
19,999 and $20,000 to $39,999 were three times more likely to be associated with ACO in 
comparison to males who earn $40,000 and over (OR$5,000 to $19,999 = 2.94; OR$20,000 to $39,999 = 
2.65). Females with an annual income between $5,000 or less income to $20,000 to $39,999 
were also significantly more likely to be associated with ACO in comparison to females who 
earn $40,000 and over (OR$5,000 or less income = 1.86; OR$5,000 to $19,999 = 3.81; OR$20,000 to $39,999 = 
3.08).  
Aboriginal males who work 80 hours and over were approximately three times more 
likely to be associated with increased risk for ACO when compared to 0 to 40 hours of paid 
hours per week (OR80 hours and over = 2.48) while females who worked 41 to 80 hours to 80 hours 
and over were significantly associated with increased risk for ACO with the same comparison 
(OR41 to 80 hours = 2.73; OR80 hours and over = 4.21).  Aboriginal males and females living in rented 
dwellings were three times more likely to be associated with ACO when compared to those 
owning the dwelling. (ORMale = 2.59; ORFemale = 2.60). 
Among lifestyle variables, Daily smoking was associated with increased risk of ACO 
in comparison to those reporting No smoking at all for both gender. (ORMales = 2.00; ORFemales 
= 2.60). Furthermore, males who report smoking at home were less likely to be associated with 
ACO (ORmales = 0.77) while females who report smoking at home were three times more likely 
to be associated with ACO (ORFemales = 2.78)  
Aboriginal people, of both genders, with a diagnosis of Diabetes type 1 and 2 were 
three times more likely to be associated with ACO compared to those without the diagnosis of 
diabetes (ORMales = 3.81; ORFemales = 3.26). 
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3.5.3 Multivariate Analysis 
The results from the multivariate analysis are shown in Table 3. In males, in comparison 
to those aged 12-34 years, males in all age groups above 45 years were increasingly associated 
with ACO while only females between 45 to 54 years were associated with ACO, Males (OR45 
to 54 years = 2.30, 95% CI = 1.09 - 4.85; OR55 to 64 years = 4.42, 95% CI = 1.89 – 10.35; OR65 and over 
= 4.99, 95% CI = 1.98 – 12.59), Females (OR45 to 54 years = 2.39, 95% CI = 1.18 - 4.85).  A linear 
relationship between the risk of ACO and age was observed in males (trend test: p<0.0001) but 
not in females (trend test: p = 0.3226). Aboriginal females who are widowed, separated or 
divorced are more than two times more likely to be associated with ACO compared to those 
who were either married or living in common-law (OR = 2.20, 95% CI = 1.17 - 4.16), no such 
associations was observed in males in terms of the p-value however the adjusted OR was 1.96.  
In comparison to those from Quebec, males from Atlantic and Territories region and 
British Columbia, females from Atlantic and Territories region, Prairies and British Columbia 
were significantly less likely to be associated with ACO. Males (ORAtlantic and Territories= 0.23, 
95% CI = 0.09 - 0.56; ORBritish Columbia = 0.36, 95% CI = 0.14 - 0.90), Females (ORAtlantic and 
Territories = 0.15, 95% CI = 0.07 - 0.31; ORPrairies= 0.41, 95% CI = 0.23 - 0.69; ORBritish Columbia = 
0.34, 95% CI = 0.18 - 0.66). Aboriginal males and females living in a dwelling in need of major 
repairs were more than two times more likely to be associated with ACO compared to those 
living in a dwelling in need of regular maintenance. (ORMales = 2.66, 95% CI = 1.37 – 5.15; 
(ORFemales = 2.59, 95% CI = 1.49 – 4.52).   
Among the socio-economic variables, males working 80 hours and over and females 
working 40 hours and over were significantly associated with increased risk of ACO when 
compared to those working 0 to 40 hours per week. Males (OR81 hours and over = 1.89, 95% CI = 
1.05 - 3.41), Females (OR41 hours to 80 hours = 3.11, 95% CI = 1.29 - 7.45; OR81 hours and over = 4.11, 
95% CI = 2.52 - 6.36). Males and females who live in a rented dwelling are approximately two 
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times more likely to be associated with ACO than those owning a dwelling (ORMales = 2.27, 
95% CI = 1.33 - 3.89; ORFemales = 1.70, 95% CI = 1.13 - 2.58). 
ln females, individuals who smoked daily were two times more likely to be associated 
with ACO compared to those that do not smoke at all (OR = 1.83, 95% CI = 1.16 - 2.90); while 
males did not show any statistical significance. In females, individuals with a diagnosis of 
diabetes (type 1 and 2) were also approximately three times more likely to be associated with 
ACO compared to those without the diagnosis of diabetes, (OR = 2.46, 95% CI = 1.52 to 3.99); 
no such association was observed in males. 
 
3.6 Discussion 
This study identified the risk factors associated with increased risk of ACO in both 
males and females which include increased age, living in Quebec, longer hours of work per 
week, living in a rented dwelling and dwelling in need of major repairs. In addition, we also 
identified the following female-specific risk factors associated with increased risk of ACO: 
being widowed, separated or divorced, a current daily smoker and having a diagnosis of 
diabetes. 
Epidemiological studies have consistently observed the association between age and 
the risk of chronic respiratory diseases.16,17 A large cross-sectional study of Aboriginal people 
in Canada reported that individuals above 50 years of age were significantly associated with 
higher risks of COPD.16 Similar results were also reported in another large cross-sectional 
study showing that older individuals above 55 years of age had a higher likelihood of Chronic 
Bronchitis (CB).17 The results from our study support the conclusions from these studies that 
increased age is associated with increased risk of ACO. In addition, we observed a linear 
relationship between increased age and a higher risk of ACO in males, not in females. In our 
analysis, a higher risk of ACO was also observed among aboriginal males and females living 
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in Quebec than other provinces of residence in Canada. A study from the US found distinct 
geographic variations in COPD hospitalization rates across the country which could be 
attributed to various environmental factors such as socioeconomic status, high-regionalized 
population rates and occupational exposures.18 Another study from the US concluded that the 
observed differences in rates of COPD exacerbation across the US could be due many reasons 
such as regional variation in provider care, environmental factors and climatic differences.19  
Furthermore, our study found that both males and females living in rented dwellings or 
dwelling in need of major repairs are associated with increased risks of ACO. There are various 
exposures that have been associated with many chronic respiratory diseases that affects the 
quality of dwellings such as physical, biological, chemical risks.20-25  A study in the US showed 
that indoor mildew odour or musty smell in dwellings were associated with risk of CB and 
asthmatic attacks.21 Efforts to improve dwelling conditions through intervention such as 
elimination of moisture intrusion have also helped reduce the effects of chronic respiratory 
diseases.25,26 
Lastly, the relationship between long work hours and chronic respiratory diseases could 
be due to low socioeconomic status (SES) which is also a known risk factor for chronic 
respiratory diseases.27-29 In our study, we found that both males and females working longer 
hours have an increased risk of ACO. Many studies have consistently reported an increased 
risk of COPD associated with low SES status.28,30 In a population-based study, it was reported 
that low SES measured by income and educational levels are independent risk factors for 
asthma and COPD respectively.31 In a study which made use of population from Finland, 
Sweden and Estonia (FinEsS Study), it was reported that female workers who are inclined to 
work longer hours were associated with increased risk for chronic respiratory symptoms such 
as CB compared to men.32 
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In our study, daily smoking is one of the female-specific risk factors associated with 
ACO. Females who reported daily smoking are approximately two times more likely to be 
associated with ACO, however this association was not observed in males. Smoking has been 
a well-known risk factor for many chronic respiratory diseases and females are more 
predisposed to the negative influence of smoking than males.33-35 A population-based study 
reported that among individuals who smoked ≥ 10 years, the prevalence of ACO was 
significantly higher in women than men.33 Another study from Denmark found a significant 
association between the risk of COPD and cigarette pack years in females only and not males.34 
Similar association between smoking pack-years and the risk of CB in females only was also 
reported in a study of two First Nations communities in Saskatchewan, Canada.35 
Increased risk of Diabetes has been associated with chronic respiratory diseases in 
many population studies.36-39 However, current literature provides inconsistent conclusion 
regarding the sex-specific association between diabetes and ACO. A cross-sectional study of 
patients hospitalized for COPD exacerbation in Spain reported that female COPD patients had 
a higher prevalence of diabetes when compared to their male counterparts.36 Although, another 
population study from Sweden reported males aged 45 years and above have an increased risk 
of diabetes type 2 than females,37 females might be more predisposed to diabetes type 1 than 
males.38 A prospective cohort study of important chronic comorbid diseases associated with 
COPD showed that males with the severe form of COPD (GOLD stage 3 or 4) had a higher 
prevalence of diabetes and hospitalization compared to females.39 The inconsistent results from 
different studies could be due to differences in study design, study population and disease 
severity. Our study supported the conclusion of significant association between increased risk 
of ACO and diagnosis of diabetes in females but not in males.   
There are fewer studies investigating the female-specific association between marital 
status and chronic respiratory diseases. A study from the US concluded that female subjects 
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who remained divorced or separated had a significantly increased risk of COPD.40 To our 
knowledge, our study is the first paper to investigate the effects of marital status and a new 
disease, ACO, among Aboriginal people. Our results suggest that Aboriginal females who are 
widowed, separated or divorced are two times more likely to be associated with ACO, and this 
was not observed in males.  
3.7 Limitations 
 This study was based on self-reported questionnaires without any objective 
measurements which are subject to misclassification. However, questionnaires using self-
reported health conditions diagnosed by a health professional have been widely used in many 
large population surveys with reasonable sensitivity and specificity.16,32 
 
3.8 Conclusion 
This study has identified many risk factors for ACO for both males and females, which 
include age, province, long hours at work, living in rented dwelling and dwelling in need of 
major repairs. It also highlights female-specific risk factors for ACO, which includes smoking 
status, marital status and diabetes. The results of our study will provide useful information for 
future development of prevention and public health intervention programs in aboriginal 
communities to reduce the burden of ACO. 
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3.1                                                    Table of Descriptive Analysis of Gender-specific risk factors 
 
Variables 
 
Labels 
Males (%) 
(n = 393,000) 
Females (%) 
(n = 459,160) 
p value 
 
ACO 
 
Yes 
 
1.65% 
 
 
3.53% 
 
<0.0001 
Age 12 to 34 years 
35 to 44years 
45 to 54 years 
55 to 64 years 
65 years and over 
47% 
17% 
17% 
12% 
7% 
44% 
18% 
18% 
12% 
8% 
0.3214 
Marital Status Married and Living in common-law 
Widowed, Separated and Divorced 
Single, never married 
51% 
8% 
41% 
45% 
18% 
37% 
<0.0001 
Rural or Urban Rural area 
Small population centre 
Medium population centre 
Large urban population centre 
26% 
21% 
11% 
42% 
23% 
21% 
12% 
44% 
0.0055 
Total Personal Income 
 
$5,000 or less income 
$5,001 to $19,999 
$20,000 to $39,999 
$40,000 and over 
27% 
19% 
22% 
32% 
24% 
29% 
28% 
19% 
<0.0001 
Province of residence Atlantic and Territories* 
Quebec 
Ontario 
Prairies 
British Columbia 
11% 
11% 
24% 
37% 
17% 
11% 
10% 
25% 
37% 
17% 
0.3862 
Smoking Status Daily 
Occasionally 
Not at all 
27% 
9% 
64% 
28% 
9% 
63% 
0.6987 
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Anybody smoking at 
home 
Yes 
No 
19% 
81% 
20% 
80% 
0.3089 
Dwelling 
(Owned/Rented) 
Owned 
Rented 
40% 
60% 
45% 
55% 
<0.0001 
Dwelling in need of 
major repairs 
Yes, major repairs are needed 
Yes, minor repairs are needed 
No, only regular maintenance is 
needed 
9% 
26% 
65% 
14% 
26% 
60% 
<0.0001 
Diabetes Diabetes type 1 and type 2 
Gestational and no diagnosis of 
diabetes 
9% 
91% 
9% 
91% 
0.8780 
How many rooms are 
there in a dwelling 
0 and 5 rooms 
6 and 8 rooms 
9 rooms and over 
48% 
31% 
21% 
50% 
32% 
18% 
0.0308 
Number of paid hours 
per week 
0 to 40 hours 
41 to 79 hours 
80 hours and over 
47% 
4% 
49% 
39% 
15% 
46% 
<0.0001 
    
*: including Nova Scotia, Newfoundland and Labrador, Prince Edward Island, New Brunswick  
         Nunavut, Yukon, Northwest Territories 
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3.2       Table of Univariate Analysis of Gender-specific risk factors 
Variables Males Females 
 % of ACO Odds Ratio (95% CI) p-value % of ACO Odds Ratio (95% CI) p-value 
Age 
  35 to 44 years 
  45 to 54 years 
  55 to 64 years 
  65 years and over 
  12 to 34 years 
 
0.79 
1.87 
3.90 
4.30 
0.85 
 
0.94 (0.32 – 2.76) 
2.21 (1.07 – 4.53) 
4.71 (2.32 – 9.58) 
5.22 (2.66 – 10.25) 
1 
 
0.9051 
0.0311 
<0.0001 
<0.0001 
 
2.39 
6.25 
4.61 
5.36 
2.23 
 
1.07 (0.57 – 2.02) 
2.93 (1.59 – 5.38) 
2.12 (1.16 – 3.89) 
2.48 (1.23 – 5.01) 
1 
 
0.8316 
0.0006 
0.0152 
0.0114 
Marital Status  
  Widowed, Separated and Divorced 
  Single, never married 
  Married and Living common-law 
 
4.62 
1.79 
1.32 
 
3.61 (1.75 – 7.44) 
1.36 (0.77 – 2.41) 
1 
 
0.0005 
0.2918 
 
7.59 
3.41 
2.39 
 
3.36 (2.00 – 5.64) 
1.45 (0.95 – 2.21) 
1 
 
<0.0001 
0.0849 
Rural or Urban        
  Rural area 
  Small population centre 
  Medium population centre 
  Large urban population centre 
 
 
1.71 
1.15 
2.18 
1.74 
 
0.98 (0.53 – 1.79) 
0.66 (0.32 – 1.36) 
1.25 (0.55 – 2.85) 
1 
 
0.9388 
0.2556 
0.5922 
 
2.62 
2.73 
4.69 
4.05 
 
0.64 (0.38 – 1.07) 
0.67 (0.42 – 1.06) 
1.16 (0.64 – 2.12) 
1 
 
0.0877 
0.0876 
0.6180 
Total Personal Income 
  $5,000 or less income 
  $5,000 to $19,999 
  $20,000 to $39,999 
  $40,000 and over 
 
1.16 
2.66 
2.41 
0.92 
 
1.26 (0.56 – 2.87) 
2.94 (1.33 – 6.45) 
2.65 (1.23 – 5.74) 
1 
 
0.5783 
0.0075 
0.0131 
 
2.57 
5.15 
4.21 
1.41 
 
1.86 (1.04 – 3.33) 
3.81 (2.28 – 6.36) 
3.08 (1.59 – 5.94) 
1 
 
0.0378 
<0.0001 
0.0008 
Province of residence 
  Atlantic and Territories** 
  Ontario 
  Prairies 
  British Columbia 
  Quebec 
 
0.79 
1.72 
1.32 
1.12 
4.38 
 
0.17 (0.07 – 0.41) 
0.38 (0.18 – 0.81) 
0.29 (0.14 – 0.62) 
0.24 (0.11 – 0.57) 
1 
 
<0.0001 
0.0125 
0.0014 
0.0011 
 
1.31 
4.78 
2.99 
2.38 
6.89 
 
 
0.18 (0.11 – 0.34) 
0.68 (0.37 – 1.25) 
0.42 (0.24 – 0.72) 
0.33 (0.18 – 0.61) 
1 
 
 
<0.0001 
0.2094 
0.0019 
0.0005 
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Type of Smoker  
  Daily 
  Occasionally 
  Not at all  
 
 
2.46 
1.46 
1.24 
 
2.00 (1.16 – 3.44) 
1.19 (0.46 – 3.08) 
1 
 
0.0122 
0.7285 
 
6.12 
3.15 
2.45 
 
2.60 (1.75 – 3.87) 
1.30 (0.67 – 2.55) 
1 
 
 
<0.0001 
0.4415 
Anybody smoking at home 
  Yes  
  No 
 
1.13 
1.46 
 
0.77 (0.43 – 1.40) 
1 
 
0.3968 
 
6.51 
2.44 
 
2.78 (1.80 – 4.29) 
1 
 
<0.0001 
Dwelling (Owned/Rented) 
  Rented 
  Owned 
 
2.53 
0.99 
 
2.59 (1.55 – 4.33) 
1 
 
0.0003 
 
5.32 
2.11 
 
2.60 (1.76- 3.85) 
1 
 
<0.0001 
Dwelling in need of major repairs 
  Yes, major repairs are needed 
  Yes, minor repairs are needed 
  No, only regular maintenance is  
  needed 
 
3.31 
1.71 
1.31 
 
2.56 (1.40 – 4.68) 
1.30 (0.72 – 2.38) 
1 
 
0.0022 
0.3870 
 
8.24 
3.11 
2.65 
 
 
3.31 (1.96 – 5.56) 
1.18 (0.76 – 1.82) 
1 
 
<0.0001 
0.4563 
Diabetes 
  Diabetes type 1 and type 2 
  Gestational and no diagnosis of   
  diabetes 
 
4.93 
1.34 
 
3.81 (2.07 – 6.95) 
1 
 
<0.0001 
 
9.17 
3.01 
 
3.26 (2.04 – 5.21) 
1 
 
<0.0001 
How many rooms are there in a 
dwelling 
  6 and 8 rooms 
  9 rooms and over 
  0 and 5 rooms 
 
 
 
1.03 
2.59 
2.56 
 
 
0.39 (0.21 – 0.79) 
0.57 (0.23 – 1.38) 
1 
 
 
0.0081 
0.2112 
 
 
2.59 
0.98 
5.06 
 
 
0.51 (0.26 – 0.95) 
0.19 (0.09 – 0.38) 
1 
 
 
0.0353 
<0.0001 
Number of paid hours per week 
  41 to 80 hours 
  80 hours and over 
  0 to 40 hours 
 
 
1.58 
2.33 
0.95 
 
1.67 (0.69 – 4.03) 
2.48 (1.41 – 4.36) 
1 
 
0.2568 
0.0016 
 
3.74 
5.67 
1.41 
 
2.73 (1.18 – 6.31) 
4.21 (2.79 – 6.37) 
1 
 
0.0188 
<0.0001 
*: including Nova Scotia, Newfoundland and Labrador, Prince Edward Island, New Brunswick, Nunavut, Yukon, Northwest Territories 
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3.3 Table of Multivariate Analysis 
Variables Male Female 
 
Age 
  35 to 44 
  45 to 54 
  55 to 64 
  65 and over 
  12 to 34 
Odds Ratio (95% CI) p-value Odds Ratio (95% CI) p-value 
 
1.07 (0.38 – 3.01) 
2.30 (1.09 – 4.85) 
4.42 (1.89 – 10.35) 
4.99 (1.98 – 12.59) 
1 
 
0.8989 
0.0286 
0.0006 
0.0007 
 
0.94 (0.48 – 1.83) 
2.39 (1.18 – 4.85) 
1.15 (0.46 – 2.86) 
0.98 (0.34 – 2.84) 
1 
 
0.8446 
0.0162 
0.7657 
0.9729 
Marital Status  
  Widowed, Separated and Divorced 
  Single, never married 
  Married and Living common-law 
 
1.95 (0.91 – 4.23) 
1.96 (0.97 – 3.97) 
1 
 
0.0917 
0.0603 
 
 
2.20 (1.17 – 4.16) 
1.46 (0.92 – 2.32) 
1 
 
0.0151 
0.1098 
Province of residence 
  Atlantic and Territories* 
  Ontario 
  Prairies 
  British Columbia 
  Quebec 
 
0.23 (0.09 – 0.56) 
0.58 (0.25 – 1.37) 
0.49 (0.21 – 1.13) 
0.36 (0.14 – 0.90) 
1 
 
0.0014 
0.2156 
0.0929 
0.0291 
 
0.15 (0.07 – 0.31) 
0.62 (0.34 – 1.12) 
0.41 (0.23 – 0.69) 
0.34 (0.18 – 0.66) 
1 
 
<0.0001 
0.1140 
0.0011 
0.0014 
 
Type of Smoker  
  Daily 
  Occasionally 
  Not at all  
 
1.36 (0.74 – 2.50) 
1.11 (0.41 – 3.08) 
1 
 
0.3211 
0.8462 
 
1.83 (1.16 – 2.90) 
0.81 (0.35 – 1.84) 
1 
 
0.0101 
0.6070 
Dwelling (Owned/Rented) 
  Rented 
  Owned 
 
2.27 (1.33 – 3.89) 
1 
 
0.0029 
 
 
1.70 (1.13 – 2.58) 
1 
 
0.0118 
Dwelling in need of major repairs 
  Yes, major repairs are needed 
  Yes, minor repairs are needed 
  No, only regular maintenance is needed 
 
 
2.66 (1.37 – 5.15) 
1.09 (0.56 – 2.10) 
1 
 
0.0037 
0.8462 
 
2.59 (1.49 – 4.52) 
1.31 (0.85 – 2.02) 
1 
 
0.0008 
0.2191 
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Diabetes 
  Diabetes type 1 and type 2 
  Gestational and no diagnosis of   
  diabetes 
 
1.56 (0.79 – 3.07) 
1 
 
0.2027 
 
 
 
2.46 (1.52 -3.99) 
1 
 
0.0003 
 
Number of paid hours per week 
  41 to 80 hours 
  81 hours and over 
  0 to 40 hours 
 
1.94 (0.79 – 4.77) 
1.89 (1.05 – 3.41) 
1 
 
0.1486 
0.0353 
 
3.11 (1.29 – 7.45) 
4.11 (2.52 – 6.36) 
1 
 
0.0112 
<0.0001 
*: including Nova Scotia, Newfoundland and Labrador, Prince Edward Island, New Brunswick, Nunavut, Yukon, Northwest Territories 
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CHAPTER 4 
GENERAL DISCUSSION AND CONCLUSIONS 
 
4.1 Summary of Research 
The main goal of the research studies in this thesis were to assess the prevalence and 
gender specific risk factors associated with ACO in Aboriginal peoples. The first study found 
out that Aboriginal peoples older than 45 years, female, widowed, separated or divorced, 
having a total personal income below $20,000 were associated with a significant risk of ACO. 
Residing in Ontario, being a daily smoker, living in a rented dwelling, dwelling in need of 
major repairs, having diabetes and working more than 40 hrs a week were also significantly 
associated with increased risk of ACO. The second study, identified the risk factors associated 
with increased risk of ACO in both males and females included increased age, living in Quebec, 
longer hours of work per week, living in a rented dwelling and dwelling in need of major 
repairs. In addition, we also identified the following female-specific risk factors associated with 
increased risk of ACO: being widowed, separated or divorced, a current daily smoker and 
having a diagnosis of diabetes. 
4.2 Summary of Results 
There are several risk facors associated with ACO in the general Aboriginal population. 
Our results showed that individuals aged between 45 to 54 years were two times more likely 
to be associated with ACO in comparison to individuals aged between 12-34 years. Aboriginal 
females were approximately two times more likely to be associated with ACO compared to 
Males. Similarly, individuals who were widowed, separated or divorced were two times more 
likely to be associated with ACO compared to individuals who were either married or living in 
common-law. In comparison to individuals from Ontario, individuals from Atlantic regions, 
Territories and British Columbia were significantly less likely to be associated with ACO. Also, 
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individuals living in dwellings in need of major repairs were two times more likely to be 
associated with ACO compared to those living in a dwelling in need of regular maintenance. 
Among the socioeconomic variables Individuals who earn between $5,000 to $19,999 
were three times more likely to be associated with ACO compared to those who earn $50,000 
to $100,000 and over. Individuals working long hours of 41 to 80 hours and 81 hours and over 
were significantly associated with ACO compared to those working 0 to 20 hours per week. 
Also, individuals who live in a rented dwelling were approximately two times more likely to 
be associated with ACO than those owning a dwelling. 
Individuals who smoke daily were found to be about two times more likely to be 
associated with ACO compared to those that do not smoke at all. Aboriginal people with 
diabetes (type 1 and 2) were also approximately two times more likely to develop ACO 
compared to those without the diagnosis of diabetes. 
 
4.3 Study Limitations 
There were several limitations to this study. The APS is a cross-sectional study, it 
suffers from all the disadvantages of a cross-sectional study, such as no casual association and 
being susceptible to recall bias since the information was collected at a specific time point. 
This study was based on self-reported questionnaires without any objective measurements 
which are subject to misclassification.  Individuals self-reported the presence of asthma and 
COPD which lacks clinical accuracy. All other answers in this survey were also self-reported 
which could underestimate the prevalence of some variables. The lack of spirometry and 
presence of confounding diseases in this population was also a limitation. 
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APPENDIX A: ETHICS APPROVAL FOR THE STUDY FROM THE NEWFOUNDLAND 
AND LABRADOR HEALTH ETHICS RESEARCH ETHICS BOARD 
 
Ethics Office Suite 200, Eastern Trust Building 95 Bonaventure Avenue St. John’s, NL A1B 
2X5 
February 15, 2018 
Suite 4M130, Medical Education Building Memorial University, 300 Prince Phillip Drive St. John's, 
NL A1B 3V6 
Dear Mr. Koleade: 
Researcher Portal File # 20171751 Reference # 2017.047 
RE: "Prevalence and risk factors of chronic respiratory diseases including asthma and COPD 
in adult Aboriginal people" 
Your application received a delegated review by a sub-committee of the Health Research Ethics 
Board (HREB). Full approval of this research study is granted for one year effective February 15, 
2018. 
This is your ethics approval only. Organizational approval may also be required. It is your 
responsibility to seek the necessary organizational approval from the Regional Health Authority 
(RHA) or other organization as appropriate. You can refer to the HREA website for further guidance 
on organizational approvals. 
This is to confirm that the HREB reviewed and approved or acknowledged the following documents 
(as indicated): 
• Application, approved 
• Research Proposal, approved 
• List of Variables, approved 
• Letter of request, approved 
• Letter of support Nunatsiavut, acknowledged 
• Budget, approved 
MARK THE DATE 
This approval will lapse on February 15, 2019 . It is your responsibility to ensure that the Ethics 
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Renewal form is submitted prior to the renewal date; you may not receive a reminder. The Ethics 
Renewal form can be found on the Researcher Portal as an Event form. 
If you do not return the completed Ethics Renewal form prior to date of renewal: 
▪ You will no longer have ethics approval 
▪ You will be required to stop research activity immediately 
▪ You may not be permitted to restart the study until you reapply for and receive approval to 
undertake the study again 
▪ Lapse in ethics approval may result in interruption or termination of funding 
You are solely responsible for providing a copy of this letter, along with your approved HREB 
application form; to Research Grant and Contract Services should your research depend on funding 
administered through that office. 
Modifications of the protocol/consent are not permitted without prior approval from the HREB. 
Implementing changes without HREB approval may result in your ethics approval being revoked, 
meaning your research must stop. Request for modification to the protocol/consent must be outlined 
on an amendment form (available on the Researcher Portal website as an Event form) and submitted 
to the HREB for review. 
The HREB operates according to the Tri-Council Policy Statement: Ethical Conduct for Research 
Involving Humans (TCPS2), the Health Research Ethics Authority Act (HREA Act) and applicable 
laws and regulations. 
You are responsible for the ethical conduct of this research, notwithstanding the approval of the 
HREB. 
We wish you every success with your study. 
Sincerely, 
Ms. Patricia Grainger (Chair, Non-Clinical Trials Health Research Ethics Board) Dr. Joy Maddigan 
(Vice-Chair, Non-Clinical Trials Health Research Ethics Board) 
CC: Dr. Zhiwei Gao 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
67 | P a g e  
 
APPENDIX B: SAS OUTPUTS 
 
UNIVARIATE ANALYSIS 
 
AGE 
 
                                   The SURVEYLOGISTIC Procedure 
 
                                   Type 3 Analysis of Effects 
 
                        Effect      F Value    Num DF    Den DF    Pr > F 
 
                        acos_age      10.14         4      1000    <.0001 
 
 
                             Analysis of Maximum Likelihood Estimates 
 
                                               Standard 
                    Parameter      Estimate       Error    t Value    Pr > |t| 
 
                    Intercept       -4.1342      0.1954     -21.16      <.0001 
                    acos_age  1      0.0683      0.2758       0.25      0.8045 
                    acos_age  2      1.0338      0.2521       4.10      <.0001 
                    acos_age  3      1.0284      0.2522       4.08      <.0001 
                    acos_age  4      1.1641      0.2698       4.31      <.0001 
                    acos_age  0           0           .        .         . 
 
                      NOTE: The degrees of freedom for the t tests is 1000. 
 
                                      Odds Ratio Estimates 
 
                                             Point       95% Confidence 
                       Effect             Estimate           Limits 
 
                       acos_age 1 vs 0       1.071       0.623       1.840 
                       acos_age 2 vs 0       2.812       1.715       4.611 
                       acos_age 3 vs 0       2.797       1.705       4.587 
                       acos_age 4 vs 0       3.203       1.886       5.439 
 
 
 
SEX 
 
                                   Type 3 Analysis of Effects 
 
                        Effect      F Value    Num DF    Den DF    Pr > F 
 
                        sex_male      22.80         1      1000    <.0001 
 
 
                             Analysis of Maximum Likelihood Estimates 
 
                                               Standard 
                    Parameter      Estimate       Error    t Value    Pr > |t| 
 
                    Intercept       -4.0873      0.1261     -32.42      <.0001 
                    sex_male  0      0.7783      0.1630       4.77      <.0001 
                    sex_male  1           0           .        .         . 
 
68 | P a g e  
 
                      NOTE: The degrees of freedom for the t tests is 1000. 
 
                                      Odds Ratio Estimates 
 
                                             Point       95% Confidence 
                       Effect             Estimate           Limits 
 
                       sex_male 0 vs 1       2.178       1.582       2.999 
 
                             
 
 
MARITAL STATUS 
                                   The SURVEYLOGISTIC Procedure 
 
                                   Type 3 Analysis of Effects 
 
                       Effect        F Value    Num DF    Den DF    Pr > F 
 
                       Mar_status      18.89         2      1000    <.0001 
 
 
                            Analysis of Maximum Likelihood Estimates 
 
                                               Standard 
                   Parameter       Estimate       Error    t Value    Pr > |t| 
 
                   Intercept        -3.9602      0.1187     -33.36      <.0001 
                   Mar_status 2      1.3357      0.2189       6.10      <.0001 
                   Mar_status 3      0.3516      0.1721       2.04      0.0413 
                   Mar_status 1           0           .        .         . 
 
                      NOTE: The degrees of freedom for the t tests is 1000. 
 
                                           
                                      Odds Ratio Estimates 
 
                                              Point       95% Confidence 
                      Effect               Estimate           Limits 
 
                      Mar_status 2 vs 1       3.803       2.475       5.843 
                      Mar_status 3 vs 1       1.421       1.014       1.992 
                           
 
 
RURAL OR URBAN 
                                   The SURVEYLOGISTIC Procedure 
 
                                    Type 3 Analysis of Effects 
 
                        Effect       F Value    Num DF    Den DF    Pr > F 
 
                        rural_urb       2.61         3      1000    0.0500 
 
 
                             Analysis of Maximum Likelihood Estimates 
 
                                               Standard 
                    Parameter      Estimate       Error    t Value    Pr > |t| 
 
                    Intercept       -3.4747      0.1216     -28.57      <.0001 
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                    rural_urb 1     -0.3334      0.1996      -1.67      0.0953 
                    rural_urb 2     -0.4176      0.2000      -2.09      0.0370 
                    rural_urb 3      0.1964      0.2513       0.78      0.4346 
                    rural_urb 4           0           .        .         . 
 
                      NOTE: The degrees of freedom for the t tests is 1000. 
 
                                       Odds Ratio Estimates 
 
                                              Point       95% Confidence 
                       Effect              Estimate           Limits 
 
                       rural_urb 1 vs 4       0.717       0.484       1.060 
                       rural_urb 2 vs 4       0.659       0.445       0.975 
                       rural_urb 3 vs 4       1.217       0.743       1.993 
 
 
 
PROVINCE OF RESIDENCE 
                                    Type 3 Analysis of Effects 
 
                        Effect       F Value    Num DF    Den DF    Pr > F 
 
                        prov_new2      10.20         5      1000    <.0001 
 
 
                             Analysis of Maximum Likelihood Estimates 
 
                                               Standard 
                    Parameter      Estimate       Error    t Value    Pr > |t| 
 
                    Intercept       -4.4843      0.2321     -19.32      <.0001 
                    prov_new2 2      1.6754      0.3009       5.57      <.0001 
                    prov_new2 3      1.1362      0.3060       3.71      0.0002 
                    prov_new2 4      0.7049      0.2682       2.63      0.0087 
                    prov_new2 5      0.4828      0.2841       1.70      0.0895 
                    prov_new2 6     -0.1029      0.3139      -0.33      0.7430 
                    prov_new2 1           0           .        .         . 
 
                                            Odds Ratio Estimates 
 
                                              Point       95% Confidence 
                       Effect              Estimate           Limits 
 
                       prov_new2 2 vs 1       5.341       2.960       9.639 
                       prov_new2 3 vs 1       3.115       1.709       5.678 
                       prov_new2 4 vs 1       2.024       1.195       3.426 
                       prov_new2 5 vs 1       1.621       0.928       2.830 
                       prov_new2 6 vs 1       0.902       0.487       1.670 
 
                            NOTE: The degrees of freedom in computing 
                                  the confidence limits is 1000. 
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TOTAL PERSONAL INCOME 
 
                                   The SURVEYLOGISTIC Procedure 
 
                                    Type 3 Analysis of Effects 
 
                      Effect           F Value    Num DF    Den DF    Pr > F 
 
                      total_harmzed      21.06         3      1000    <.0001 
 
 
                             Analysis of Maximum Likelihood Estimates 
 
                                                 Standard 
                  Parameter          Estimate       Error    t Value    Pr > |t| 
 
                  Intercept           -2.7776      0.1282     -21.67      <.0001 
                  total_harmzed 1     -1.0560      0.2365      -4.46      <.0001 
                  total_harmzed 3     -1.0265      0.1947      -5.27      <.0001 
                  total_harmzed 4     -2.0353      0.3028      -6.72      <.0001 
                  total_harmzed 2           0           .        .         . 
 
                      NOTE: The degrees of freedom for the t tests is 1000. 
 
                                       Odds Ratio Estimates 
 
                                                Point       95% Confidence 
                     Effect                  Estimate           Limits 
 
                     total_harmzed 1 vs 2       0.348       0.219       0.553 
                     total_harmzed 3 vs 2       0.358       0.245       0.525 
                     total_harmzed 4 vs 2       0.131       0.072       0.237 
 
 
 
 
 
SMOKING STATUS 
 
 
                                   The SURVEYLOGISTIC Procedure 
 
                                    Type 3 Analysis of Effects 
 
                         Effect     F Value    Num DF    Den DF    Pr > F 
 
                         smk_typ      15.99         2      1000    <.0001 
 
 
                             Analysis of Maximum Likelihood Estimates 
 
                                               Standard 
                    Parameter      Estimate       Error    t Value    Pr > |t| 
 
                    Intercept       -3.9487      0.1208     -32.68      <.0001 
                    smk_typ   1      0.8874      0.1587       5.59      <.0001 
                    smk_typ   2      0.2324      0.2827       0.82      0.4112 
                    smk_typ   0           0           .        .         . 
 
                      NOTE: The degrees of freedom for the t tests is 1000. 
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                                       Odds Ratio Estimates 
 
                                             Point       95% Confidence 
                        Effect            Estimate           Limits 
 
                        smk_typ 1 vs 0       2.429       1.779       3.316 
                        smk_typ 2 vs 0       1.262       0.724       2.197 
 
 
ANYBODY SMOKING AT HOME 
 
                                           
                                   The SURVEYLOGISTIC Procedure 
 
                                    Type 3 Analysis of Effects 
 
                         Effect     F Value    Num DF    Den DF    Pr > F 
 
                         smk_hom      14.89         1      1000    0.0001 
 
 
                             Analysis of Maximum Likelihood Estimates 
 
                                               Standard 
                    Parameter      Estimate       Error    t Value    Pr > |t| 
 
                    Intercept       -3.8961      0.1081     -36.04      <.0001 
                    smk_hom   1      0.7144      0.1851       3.86      0.0001 
                    smk_hom   0           0           .        .         . 
 
                      NOTE: The degrees of freedom for the t tests is 1000. 
 
                                       Odds Ratio Estimates 
 
                                             Point       95% Confidence 
                        Effect            Estimate           Limits 
 
                        smk_hom 1 vs 0       2.043       1.421       2.938 
 
 
 
DWELLING (OWNED/RENTED) 
 
                                   The SURVEYLOGISTIC Procedure 
 
                                    Type 3 Analysis of Effects 
 
                        Effect       F Value    Num DF    Den DF    Pr > F 
 
                        hou_owned      37.00         1      1000    <.0001 
 
 
                             Analysis of Maximum Likelihood Estimates 
 
                                               Standard 
                    Parameter      Estimate       Error    t Value    Pr > |t| 
 
                    Intercept       -4.1349      0.1124     -36.78      <.0001 
                    hou_owned 0      0.9883      0.1625       6.08      <.0001 
                    hou_owned 1           0           .        .         . 
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                      NOTE: The degrees of freedom for the t tests is 1000. 
 
                                       Odds Ratio Estimates 
 
                                              Point       95% Confidence 
                       Effect              Estimate           Limits 
 
                       hou_owned 0 vs 1       2.687       1.953       3.695 
 
 
DWELLING IN NEED OF MAJOR REPAIRS 
 
                                   The SURVEYLOGISTIC Procedure 
 
                                    Type 3 Analysis of Effects 
 
                         Effect     F Value    Num DF    Den DF    Pr > F 
 
                         hou_rep      16.55         2      1000    <.0001 
 
 
                             Analysis of Maximum Likelihood Estimates 
 
                                               Standard 
                    Parameter      Estimate       Error    t Value    Pr > |t| 
 
                    Intercept       -3.8872      0.1125     -34.54      <.0001 
                    hou_rep   1      1.2101      0.2170       5.58      <.0001 
                    hou_rep   2      0.2117      0.1849       1.14      0.2525 
                    hou_rep   0           0           .        .         . 
 
                      NOTE: The degrees of freedom for the t tests is 1000. 
 
                                       Odds Ratio Estimates 
 
                                             Point       95% Confidence 
                        Effect            Estimate           Limits 
 
                        hou_rep 1 vs 0       3.354       2.191       5.134 
                        hou_rep 2 vs 0       1.236       0.860       1.776 
 
                             
 
DIABETES 
                                   The SURVEYLOGISTIC Procedure 
 
                                    Type 3 Analysis of Effects 
 
                       Effect         F Value    Num DF    Den DF    Pr > F 
 
                       diab_type12      41.61         1      1000    <.0001 
 
 
                             Analysis of Maximum Likelihood Estimates 
 
                                                Standard 
                   Parameter        Estimate       Error    t Value    Pr > |t| 
 
                   Intercept         -3.7747      0.0967     -39.02      <.0001 
                   diab_type12 1      1.2188      0.1889       6.45      <.0001 
                   diab_type12 0           0           .        .         . 
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                      NOTE: The degrees of freedom for the t tests is 1000. 
Odds Ratio Estimates 
 
                                               Point       95% Confidence 
                      Effect                Estimate           Limits 
 
                      diab_type12 1 vs 0       3.383       2.335       4.901 
 
 
 
HOW MANY ROOMS ARE THERE IN A DWELLING 
 
                                   The SURVEYLOGISTIC Procedure 
 
                                   Type 3 Analysis of Effects 
 
                        Effect      F Value    Num DF    Den DF    Pr > F 
 
                        hous_rms       8.71         3      1000    <.0001 
 
 
                             Analysis of Maximum Likelihood Estimates 
 
                                               Standard 
                    Parameter      Estimate       Error    t Value    Pr > |t| 
 
                    Intercept       -2.8297      0.2436     -11.62      <.0001 
                    hous_rms  2     -0.4290      0.2709      -1.58      0.1136 
                    hous_rms  3     -1.1308      0.3439      -3.29      0.0010 
                    hous_rms  4     -1.5568      0.3715      -4.19      <.0001 
                    hous_rms  1           0           .        .         . 
 
                      NOTE: The degrees of freedom for the t tests is 1000. 
 
                                      Odds Ratio Estimates 
 
                                             Point       95% Confidence 
                       Effect             Estimate           Limits 
 
                       hous_rms 2 vs 1       0.651       0.383       1.108 
                       hous_rms 3 vs 1       0.323       0.164       0.634 
                       hous_rms 4 vs 1       0.211       0.102       0.437 
 
 
NUMBER OF PAID HOURS PER WEEK 
 
                                   The SURVEYLOGISTIC Procedure 
 
                                    Type 3 Analysis of Effects 
 
                         Effect     F Value    Num DF    Den DF    Pr > F 
 
                         hrs_wrk      19.92         3      1000    <.0001 
 
 
                             Analysis of Maximum Likelihood Estimates 
 
                                               Standard 
                    Parameter      Estimate       Error    t Value    Pr > |t| 
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                    Intercept       -4.4195      0.3415     -12.94      <.0001 
                    hrs_wrk   2      0.0274      0.3653       0.08      0.9402 
                    hrs_wrk   3      0.5734      0.4359       1.32      0.1887 
                    hrs_wrk   4      1.2936      0.3553       3.64      0.0003 
                    hrs_wrk   1           0           .        .         . 
 
                                        
 
Odds Ratio Estimates 
 
                                             Point       95% Confidence 
                        Effect            Estimate           Limits 
 
                        hrs_wrk 2 vs 1       1.028       0.502       2.105 
                        hrs_wrk 3 vs 1       1.774       0.754       4.173 
                        hrs_wrk 4 vs 1       3.646       1.816       7.322 
 
 
 
FINAL MODEL: MULTIVARIATE ANALYSIS 
                                                                              
                                   The SURVEYLOGISTIC Procedure 
 
                                    Type 3 Analysis of Effects 
 
                      Effect           F Value    Num DF    Den DF    Pr > F 
 
                      acos_age            3.65         4      1000    0.0058 
                      sex_male           10.47         1      1000    0.0013 
                      Mar_status          4.80         2      1000    0.0084 
                      total_harmzed       4.43         3      1000    0.0042 
                      prov_new2           9.71         5      1000    <.0001 
                      smk_typ             4.24         2      1000    0.0147 
                      hou_owned           9.82         1      1000    0.0018 
                      hou_rep             6.54         2      1000    0.0015 
                      diab_type12         5.54         1      1000    0.0188 
                      hrs_wrk             7.56         3      1000    <.0001 
 
                                           
                                   The SURVEYLOGISTIC Procedure 
 
                             Analysis of Maximum Likelihood Estimates 
 
                                                 Standard 
                  Parameter          Estimate       Error    t Value    Pr > |t| 
 
                  Intercept           -6.5037      0.5152     -12.62      <.0001 
                  acos_age      1     0.00561      0.3153       0.02      0.9858 
                  acos_age      2      0.8894      0.3037       2.93      0.0035 
                  acos_age      3      0.6903      0.3663       1.88      0.0597 
                  acos_age      4      0.5175      0.4408       1.17      0.2406 
                  acos_age      0           0           .        .         . 
                  sex_male      0      0.5564      0.1720       3.23      0.0013 
                  sex_male      1           0           .        .         . 
                  Mar_status    2      0.6774      0.2547       2.66      0.0080 
                  Mar_status    3      0.3647      0.2154       1.69      0.0908 
                  Mar_status    1           0           .        .         . 
                  total_harmzed 1      0.4637      0.4079       1.14      0.2559 
                  total_harmzed 2      1.0983      0.3723       2.95      0.0033 
                  total_harmzed 3      0.5896      0.3601       1.64      0.1019 
                  total_harmzed 4           0           .        .         . 
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                  prov_new2     1     -1.1592      0.3399      -3.41      0.0007 
                  prov_new2     2      0.4549      0.2625       1.73      0.0834 
                  prov_new2     4     -0.3150      0.2272      -1.39      0.1660 
                  prov_new2     5     -0.6659      0.2754      -2.42      0.0158 
                  prov_new2     6     -1.5462      0.3116      -4.96      <.0001 
                  prov_new2     3           0           .        .         . 
                  smk_typ       1      0.5046      0.1911       2.64      0.0084 
                  smk_typ       2    -0.00438      0.3348      -0.01      0.9896 
                  smk_typ       0           0           .        .         . 
                  hou_owned     0      0.5660      0.1806       3.13      0.0018 
                  hou_owned     1           0           .        .         . 
                  hou_rep       1      0.8353      0.2347       3.56      0.0004 
                  hou_rep       2      0.1441      0.1941       0.74      0.4579 
                  hou_rep       0           0           .        .         . 
                  diab_type12   1      0.5171      0.2197       2.35      0.0188 
                  diab_type12   0           0           .        .         . 
                  hrs_wrk       2      0.1460      0.3794       0.38      0.7004 
                  hrs_wrk       3      1.0414      0.4711       2.21      0.0273 
                  hrs_wrk       4      1.0455      0.3776       2.77      0.0057 
                  hrs_wrk       1           0           .        .         . 
 
                      NOTE: The degrees of freedom for the t tests is 1000. 
 
                                      Odds Ratio Estimates 
 
                                                Point       95% Confidence 
                     Effect                  Estimate           Limits 
 
                     acos_age      1 vs 0       1.006       0.542       1.867 
                     acos_age      2 vs 0       2.434       1.341       4.417 
                     acos_age      3 vs 0       1.994       0.972       4.092 
                     acos_age      4 vs 0       1.678       0.706       3.985 
                     sex_male      0 vs 1       1.744       1.245       2.445 
                     Mar_status    2 vs 1       1.969       1.194       3.245 
                     Mar_status    3 vs 1       1.440       0.944       2.198 
                     total_harmzed 1 vs 4       1.590       0.714       3.540 
                     total_harmzed 2 vs 4       2.999       1.444       6.227 
                     total_harmzed 3 vs 4       1.803       0.890       3.656 
                     prov_new2     1 vs 3       0.314       0.161       0.611 
                     prov_new2     2 vs 3       1.576       0.942       2.638 
                     prov_new2     4 vs 3       0.730       0.467       1.140 
                     prov_new2     5 vs 3       0.514       0.299       0.882 
                     prov_new2     6 vs 3       0.213       0.116       0.393 
                     smk_typ       1 vs 0       1.656       1.138       2.410 
                     smk_typ       2 vs 0       0.996       0.516       1.921 
                     hou_owned     0 vs 1       1.761       1.236       2.510 
                     hou_rep       1 vs 0       2.306       1.455       3.654 
                     hou_rep       2 vs 0       1.155       0.789       1.690 
                     diab_type12   1 vs 0       1.677       1.090       2.581 
                     hrs_wrk       2 vs 1       1.157       0.550       2.437 
                     hrs_wrk       3 vs 1       2.833       1.124       7.140 
                     hrs_wrk       4 vs 1       2.845       1.356       5.968 
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UNIVARIATE ANALYSIS FOR GENDER-SPECIFIC ANALYSIS 
 
AGE 
 
Male 
 
                              Domain Analysis for domain sex_male=1 
 
                                   Type 3 Analysis of Effects 
 
                        Effect      F Value    Num DF    Den DF    Pr > F 
 
                        acos_age       8.85         4      1000    <.0001 
 
 
                             Analysis of Maximum Likelihood Estimates 
 
                                               Standard 
                    Parameter      Estimate       Error    t Value    Pr > |t| 
 
                    Intercept       -4.7556      0.2293     -20.74      <.0001 
                    acos_age  1     -0.0657      0.5506      -0.12      0.9051 
                    acos_age  2      0.7910      0.3665       2.16      0.0311 
                    acos_age  3      1.5504      0.3616       4.29      <.0001 
                    acos_age  4      1.6525      0.3439       4.81      <.0001 
                    acos_age  0           0           .        .         . 
 
                      NOTE: The degrees of freedom for the t tests is 1000. 
 
 
                                      Odds Ratio Estimates 
 
                                             Point       95% Confidence 
                       Effect             Estimate           Limits 
 
                       acos_age 1 vs 0       0.936       0.318       2.759 
                       acos_age 2 vs 0       2.206       1.074       4.527 
                       acos_age 3 vs 0       4.713       2.318       9.583 
                       acos_age 4 vs 0       5.220       2.658      10.251 
 
 
 
Female 
                                        
                              Domain Analysis for domain sex_male=0 
 
                                   Type 3 Analysis of Effects 
 
                        Effect      F Value    Num DF    Den DF    Pr > F 
 
                        acos_age       5.21         4      1000    0.0004 
 
 
                             Analysis of Maximum Likelihood Estimates 
 
                                               Standard 
                    Parameter      Estimate       Error    t Value    Pr > |t| 
 
                    Intercept       -3.7804      0.2460     -15.37      <.0001 
                    acos_age  1      0.0687      0.3230       0.21      0.8316 
77 | P a g e  
 
                    acos_age  2      1.0735      0.3108       3.45      0.0006 
                    acos_age  3      0.7517      0.3090       2.43      0.0152 
                    acos_age  4      0.9084      0.3586       2.53      0.0114 
                    acos_age  0           0           .        .         . 
 
                                      Odds Ratio Estimates 
 
                                             Point       95% Confidence 
                       Effect             Estimate           Limits 
 
                       acos_age 1 vs 0       1.071       0.568       2.019 
                       acos_age 2 vs 0       2.925       1.590       5.383 
                       acos_age 3 vs 0       2.121       1.156       3.889 
                       acos_age 4 vs 0       2.480       1.227       5.013 
 
 
MARITAL STATUS 
 
Male 
                              Domain Analysis for domain sex_male=1 
 
                                   Type 3 Analysis of Effects 
 
                       Effect        F Value    Num DF    Den DF    Pr > F 
 
                       Mar_status       6.05         2      1000    0.0025 
 
 
  
 
 
 
 
                           Analysis of Maximum Likelihood Estimates 
 
                                               Standard 
                   Parameter       Estimate       Error    t Value    Pr > |t| 
 
                   Intercept        -4.3113      0.1929     -22.35      <.0001 
                   Mar_status 2      1.2826      0.3690       3.48      0.0005 
                   Mar_status 3      0.3072      0.2913       1.05      0.2918 
                   Mar_status 1           0           .        .         . 
 
                                      Odds Ratio Estimates 
 
                                              Point       95% Confidence 
                      Effect               Estimate           Limits 
 
                      Mar_status 2 vs 1       3.606       1.748       7.439 
                      Mar_status 3 vs 1       1.360       0.768       2.408 
 
 
Female 
 
                              Domain Analysis for domain sex_male=0 
 
                                   Type 3 Analysis of Effects 
 
                       Effect        F Value    Num DF    Den DF    Pr > F 
 
                       Mar_status      10.66         2      1000    <.0001 
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                            Analysis of Maximum Likelihood Estimates 
 
                                               Standard 
                   Parameter       Estimate       Error    t Value    Pr > |t| 
 
                   Intercept        -3.7125      0.1557     -23.84      <.0001 
                   Mar_status 2      1.2122      0.2639       4.59      <.0001 
                   Mar_status 3      0.3699      0.2145       1.72      0.0849 
                   Mar_status 1           0           .        .         . 
 
                                      Odds Ratio Estimates 
 
                                              Point       95% Confidence 
                      Effect               Estimate           Limits 
 
                      Mar_status 2 vs 1       3.361       2.002       5.641 
                      Mar_status 3 vs 1       1.448       0.950       2.205 
 
 
 
RURAL OR URBAN 
 
Male 
 
                              Domain Analysis for domain sex_male=1 
 
                                    Type 3 Analysis of Effects 
 
                        Effect       F Value    Num DF    Den DF    Pr > F 
 
                        rural_urb       0.65         3      1000    0.5803 
 
 
                             Analysis of Maximum Likelihood Estimates 
 
                                               Standard 
                    Parameter      Estimate       Error    t Value    Pr > |t| 
 
                    Intercept       -4.0326      0.1959     -20.58      <.0001 
                    rural_urb 1     -0.0237      0.3080      -0.08      0.9388 
                    rural_urb 2     -0.4225      0.3714      -1.14      0.2556 
                    rural_urb 3      0.2243      0.4187       0.54      0.5922 
                    rural_urb 4           0           .        .         . 
 
                                       Odds Ratio Estimates 
 
                                              Point       95% Confidence 
                       Effect              Estimate           Limits 
 
                       rural_urb 1 vs 4       0.977       0.534       1.787 
                       rural_urb 2 vs 4       0.655       0.316       1.358 
                       rural_urb 3 vs 4       1.252       0.550       2.846 
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Female 
 
                              Domain Analysis for domain sex_male=0 
 
                                    Type 3 Analysis of Effects 
 
                        Effect       F Value    Num DF    Den DF    Pr > F 
 
                        rural_urb       1.98         3      1000    0.1146 
 
 
                             Analysis of Maximum Likelihood Estimates 
 
                                               Standard 
                    Parameter      Estimate       Error    t Value    Pr > |t| 
 
                    Intercept       -3.1654      0.1509     -20.98      <.0001 
                    rural_urb 1     -0.4509      0.2638      -1.71      0.0877 
                    rural_urb 2     -0.4070      0.2380      -1.71      0.0876 
                    rural_urb 3      0.1519      0.3045       0.50      0.6180 
                    rural_urb 4           0           .        .         . 
 
                                       Odds Ratio Estimates 
 
                                              Point       95% Confidence 
                       Effect              Estimate           Limits 
 
                       rural_urb 1 vs 4       0.637       0.380       1.069 
                       rural_urb 2 vs 4       0.666       0.417       1.062 
                       rural_urb 3 vs 4       1.164       0.640       2.116 
 
 
 
 
PROVINCE OF RESIDENCE 
 
Male 
                              Domain Analysis for domain sex_male=1 
 
                                    Type 3 Analysis of Effects 
 
                        Effect       F Value    Num DF    Den DF    Pr > F 
 
                        prov_new2       4.74         4      1000    0.0009 
 
 
                             Analysis of Maximum Likelihood Estimates 
 
                                               Standard 
                    Parameter      Estimate       Error    t Value    Pr > |t| 
 
                    Intercept       -3.0803      0.3073     -10.03      <.0001 
                    prov_new2 1     -1.7535      0.4342      -4.04      <.0001 
                    prov_new2 3     -0.9656      0.3859      -2.50      0.0125 
                    prov_new2 4     -1.2337      0.3860      -3.20      0.0014 
                    prov_new2 5     -1.4003      0.4281      -3.27      0.0011 
                    prov_new2 2           0           .        .         . 
 
 
                                       Odds Ratio Estimates 
 
                                              Point       95% Confidence 
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                       Effect              Estimate           Limits 
 
                       prov_new2 1 vs 2       0.173       0.074       0.406 
                       prov_new2 3 vs 2       0.381       0.179       0.812 
                       prov_new2 4 vs 2       0.291       0.137       0.621 
                       prov_new2 5 vs 2       0.247       0.106       0.571 
 
Female 
 
                              Domain Analysis for domain sex_male=0 
 
                                    Type 3 Analysis of Effects 
 
                        Effect       F Value    Num DF    Den DF    Pr > F 
 
                        prov_new2       7.98         4      1000    <.0001 
 
 
                             Analysis of Maximum Likelihood Estimates 
 
                                               Standard 
                    Parameter      Estimate       Error    t Value    Pr > |t| 
 
                    Intercept       -2.6015      0.2326     -11.19      <.0001 
                    prov_new2 1     -1.7131      0.3216      -5.33      <.0001 
                    prov_new2 3     -0.3897      0.3103      -1.26      0.2094 
                    prov_new2 4     -0.8756      0.2810      -3.12      0.0019 
                    prov_new2 5     -1.1097      0.3166      -3.51      0.0005 
                    prov_new2 2           0           .        .         . 
 
                      NOTE: The degrees of freedom for the t tests is 1000. 
 
 
                                       Odds Ratio Estimates 
 
                                              Point       95% Confidence 
                       Effect              Estimate           Limits 
 
                       prov_new2 1 vs 2       0.180       0.096       0.339 
                       prov_new2 3 vs 2       0.677       0.368       1.245 
                       prov_new2 4 vs 2       0.417       0.240       0.723 
                       prov_new2 5 vs 2       0.330       0.177       0.614 
 
                                         
TOTAL PERSONAL INCOME 
 
Male 
 
                              Domain Analysis for domain sex_male=1 
 
                                    Type 3 Analysis of Effects 
 
                         Effect     F Value    Num DF    Den DF    Pr > F 
 
                         tot_inc       3.61         3      1000    0.0130 
 
 
                             Analysis of Maximum Likelihood Estimates 
 
                                               Standard 
                    Parameter      Estimate       Error    t Value    Pr > |t| 
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                    Intercept       -4.6779      0.3106     -15.06      <.0001 
                    tot_inc   1      0.2325      0.4182       0.56      0.5783 
                    tot_inc   2      1.0770      0.4018       2.68      0.0075 
                    tot_inc   3      0.9761      0.3929       2.48      0.0131 
                    tot_inc   4           0           .        .         . 
 
 
                                       Odds Ratio Estimates 
 
                                             Point       95% Confidence 
                        Effect            Estimate           Limits 
 
                        tot_inc 1 vs 4       1.262       0.555       2.867 
                        tot_inc 2 vs 4       2.936       1.334       6.459 
                        tot_inc 3 vs 4       2.654       1.228       5.738 
 
 
Female 
 
                              Domain Analysis for domain sex_male=0 
 
                                    Type 3 Analysis of Effects 
 
                         Effect     F Value    Num DF    Den DF    Pr > F 
 
                         tot_inc       9.88         3      1000    <.0001 
 
 
                             Analysis of Maximum Likelihood Estimates 
 
                                               Standard 
                    Parameter      Estimate       Error    t Value    Pr > |t| 
 
                    Intercept       -4.2523      0.2236     -19.01      <.0001 
                    tot_inc   1      0.6186      0.2974       2.08      0.0378 
                    tot_inc   2      1.3380      0.2609       5.13      <.0001 
                    tot_inc   3      1.1243      0.3355       3.35      0.0008 
                    tot_inc   4           0           .        .         . 
 
 
                                       Odds Ratio Estimates 
 
                                             Point       95% Confidence 
                        Effect            Estimate           Limits 
 
                        tot_inc 1 vs 4       1.856       1.036       3.328 
                        tot_inc 2 vs 4       3.811       2.284       6.360 
                        tot_inc 3 vs 4       3.078       1.594       5.946 
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SMOKING STATUS 
 
Male 
 
                              Domain Analysis for domain sex_male=1 
 
                                    Type 3 Analysis of Effects 
 
                         Effect     F Value    Num DF    Den DF    Pr > F 
 
                         smk_typ       3.21         2      1000    0.0407 
 
 
                             Analysis of Maximum Likelihood Estimates 
 
                                               Standard 
                    Parameter      Estimate       Error    t Value    Pr > |t| 
 
                    Intercept       -4.3753      0.1806     -24.22      <.0001 
                    smk_typ   1      0.6928      0.2758       2.51      0.0122 
                    smk_typ   2      0.1695      0.4880       0.35      0.7285 
                    smk_typ   0           0           .        .         . 
 
 
                                       Odds Ratio Estimates 
 
                                             Point       95% Confidence 
                        Effect            Estimate           Limits 
 
                        smk_typ 1 vs 0       1.999       1.164       3.435 
                        smk_typ 2 vs 0       1.185       0.455       3.087 
 
                             
 
Females 
 
                              Domain Analysis for domain sex_male=0 
 
                                    Type 3 Analysis of Effects 
 
                         Effect     F Value    Num DF    Den DF    Pr > F 
 
                         smk_typ      11.28         2      1000    <.0001 
 
 
                             Analysis of Maximum Likelihood Estimates 
 
                                               Standard 
                    Parameter      Estimate       Error    t Value    Pr > |t| 
 
                    Intercept       -3.6856      0.1574     -23.41      <.0001 
                    smk_typ   1      0.9552      0.2032       4.70      <.0001 
                    smk_typ   2      0.2640      0.3429       0.77      0.4415 
                    smk_typ   0           0           .        .         . 
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ANYBODY SMOKING AT HOME 
 
Male 
                                         
                              Domain Analysis for domain sex_male=1 
 
                                    Type 3 Analysis of Effects 
 
                         Effect     F Value    Num DF    Den DF    Pr > F 
 
                         smk_hom       0.72         1      1000    0.3968 
 
 
                             Analysis of Maximum Likelihood Estimates 
 
                                               Standard 
                    Parameter      Estimate       Error    t Value    Pr > |t| 
 
                    Intercept       -4.2141      0.1606     -26.25      <.0001 
                    smk_hom   1     -0.2580      0.3044      -0.85      0.3968 
                    smk_hom   0           0           .        .         . 
 
                                       Odds Ratio Estimates 
 
                                             Point       95% Confidence 
                        Effect            Estimate           Limits 
 
                        smk_hom 1 vs 0       0.773       0.425       1.404 
 
Female 
 
 
                              Domain Analysis for domain sex_male=0 
 
                                    Type 3 Analysis of Effects 
 
                         Effect     F Value    Num DF    Den DF    Pr > F 
 
                         smk_hom      21.48         1      1000    <.0001 
 
 
                             Analysis of Maximum Likelihood Estimates 
 
                                               Standard 
                    Parameter      Estimate       Error    t Value    Pr > |t| 
 
                    Intercept       -3.6891      0.1395     -26.44      <.0001 
                    smk_hom   1      1.0238      0.2209       4.63      <.0001 
                    smk_hom   0           0           .        .         . 
 
                                       Odds Ratio Estimates 
 
                                             Point       95% Confidence 
                        Effect            Estimate           Limits 
 
                        smk_hom 1 vs 0       2.784       1.804       4.294 
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DWELLING (OWNED/RENTED) 
 
Male 
 
                              Domain Analysis for domain sex_male=1 
 
                                    Type 3 Analysis of Effects 
 
                        Effect       F Value    Num DF    Den DF    Pr > F 
 
                        hou_owned      13.10         1      1000    0.0003 
 
 
                             Analysis of Maximum Likelihood Estimates 
 
                                               Standard 
                    Parameter      Estimate       Error    t Value    Pr > |t| 
 
                    Intercept       -4.6035      0.1890     -24.35      <.0001 
                    hou_owned 0      0.9500      0.2624       3.62      0.0003 
                    hou_owned 1           0           .        .         . 
 
 
                                       Odds Ratio Estimates 
 
                                              Point       95% Confidence 
                       Effect              Estimate           Limits 
 
                       hou_owned 0 vs 1       2.586       1.545       4.328 
 
 
Female 
                              Domain Analysis for domain sex_male=0 
 
                                    Type 3 Analysis of Effects 
 
                        Effect       F Value    Num DF    Den DF    Pr > F 
 
                        hou_owned      22.90         1      1000    <.0001 
 
 
                             Analysis of Maximum Likelihood Estimates 
 
                                               Standard 
                    Parameter      Estimate       Error    t Value    Pr > |t| 
 
                    Intercept       -3.8358      0.1428     -26.87      <.0001 
                    hou_owned 0      0.9570      0.2000       4.79      <.0001 
                    hou_owned 1           0           .        .         . 
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DWELLING IN NEED OF REPAIRS 
 
Male                                          
                              Domain Analysis for domain sex_male=1 
 
                                    Type 3 Analysis of Effects 
 
                         Effect     F Value    Num DF    Den DF    Pr > F 
 
                         hou_rep       4.72         2      1000    0.0091 
 
 
                             Analysis of Maximum Likelihood Estimates 
 
                                               Standard 
                    Parameter      Estimate       Error    t Value    Pr > |t| 
 
                    Intercept       -4.3209      0.1828     -23.64      <.0001 
                    hou_rep   1      0.9405      0.3069       3.07      0.0022 
                    hou_rep   2      0.2647      0.3059       0.87      0.3870 
                    hou_rep   0           0           .        .         . 
 
                                       Odds Ratio Estimates 
 
                                             Point       95% Confidence 
                        Effect            Estimate           Limits 
 
                        hou_rep 1 vs 0       2.561       1.403       4.677 
                        hou_rep 2 vs 0       1.303       0.715       2.375 
 
                             
Female 
                              Domain Analysis for domain sex_male=0 
 
                                    Type 3 Analysis of Effects 
 
                         Effect     F Value    Num DF    Den DF    Pr > F 
 
                         hou_rep      10.75         2      1000    <.0001 
 
                             Analysis of Maximum Likelihood Estimates 
 
                                               Standard 
                    Parameter      Estimate       Error    t Value    Pr > |t| 
 
                    Intercept       -3.6042      0.1341     -26.88      <.0001 
                    hou_rep   1      1.1938      0.2662       4.49      <.0001 
                    hou_rep   2      0.1651      0.2215       0.75      0.4563 
                    hou_rep   0           0           .        .         . 
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DIABETES 
 
Male 
                              Domain Analysis for domain sex_male=1 
 
                                    Type 3 Analysis of Effects 
 
                       Effect         F Value    Num DF    Den DF    Pr > F 
 
                       diab_type12      18.68         1      1000    <.0001 
 
 
                             Analysis of Maximum Likelihood Estimates 
 
                                                Standard 
                   Parameter        Estimate       Error    t Value    Pr > |t| 
 
                   Intercept         -4.2957      0.1460     -29.42      <.0001 
                   diab_type12 1      1.3336      0.3085       4.32      <.0001 
                   diab_type12 0           0           .        .         . 
 
                                       Odds Ratio Estimates 
 
                                               Point       95% Confidence 
                      Effect                Estimate           Limits 
 
                      diab_type12 1 vs 0       3.795       2.071       6.952 
 
Female 
 
                              Domain Analysis for domain sex_male=0 
 
                                    Type 3 Analysis of Effects 
 
                       Effect         F Value    Num DF    Den DF    Pr > F 
 
                       diab_type12      24.46         1      1000    <.0001 
 
 
                             Analysis of Maximum Likelihood Estimates 
 
                                                Standard 
                   Parameter        Estimate       Error    t Value    Pr > |t| 
 
                   Intercept         -3.4742      0.1215     -28.60      <.0001 
                   diab_type12 1      1.1818      0.2389       4.95      <.0001 
                   diab_type12 0           0           .        .         . 
 
                                       Odds Ratio Estimates 
 
                                               Point       95% Confidence 
                      Effect                Estimate           Limits 
 
                      diab_type12 1 vs 0       3.260       2.040       5.211 
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HOW MANY ROOMS ARE THERE IN A BUILDING 
 
Male 
Domain Analysis for domain sex_male=1 
 
                                   Type 3 Analysis of Effects 
 
                        Effect      F Value    Num DF    Den DF    Pr > F 
 
                        hous_rms       3.77         2      1000    0.0233 
 
 
                             Analysis of Maximum Likelihood Estimates 
 
                                               Standard 
                    Parameter      Estimate       Error    t Value    Pr > |t| 
 
                    Intercept       -3.6396      0.1810     -20.11      <.0001 
                    hous_rms  3     -0.9305      0.3510      -2.65      0.0081 
                    hous_rms  4     -0.5657      0.4522      -1.25      0.2112 
                    hous_rms  1           0           .        .         . 
                                      Odds Ratio Estimates 
 
                                             Point       95% Confidence 
                       Effect             Estimate           Limits 
 
                       hous_rms 3 vs 1       0.394       0.198       0.785 
                       hous_rms 4 vs 1       0.568       0.234       1.379 
 
Female  
 
                             Domain Analysis for domain sex_male=0 
 
                                   Type 3 Analysis of Effects 
 
                        Effect      F Value    Num DF    Den DF    Pr > F 
 
                        hous_rms      11.94         2      1000    <.0001 
 
 
                             Analysis of Maximum Likelihood Estimates 
 
                                               Standard 
                    Parameter      Estimate       Error    t Value    Pr > |t| 
 
                    Intercept       -2.9309      0.1325     -22.12      <.0001 
                    hous_rms  3     -0.6991      0.3317      -2.11      0.0353 
                    hous_rms  4     -1.6858      0.3647      -4.62      <.0001 
                    hous_rms  1           0           .        .         . 
 
                                      Odds Ratio Estimates 
 
                                             Point       95% Confidence 
                       Effect             Estimate           Limits 
 
                       hous_rms 3 vs 1       0.497       0.259       0.953 
                       hous_rms 4 vs 1       0.185       0.091       0.379 
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NUMBER OF PAID HOURS PER WEEK 
 
Male 
 
                              Domain Analysis for domain sex_male=1 
 
                                    Type 3 Analysis of Effects 
 
                         Effect     F Value    Num DF    Den DF    Pr > F 
 
                         hrs_wrk       5.03         2      1000    0.0067 
 
 
                             Analysis of Maximum Likelihood Estimates 
 
                                               Standard 
                    Parameter      Estimate       Error    t Value    Pr > |t| 
 
                    Intercept       -4.6434      0.2313     -20.08      <.0001 
                    hrs_wrk   3      0.5105      0.4499       1.13      0.2568 
                    hrs_wrk   4      0.9090      0.2871       3.17      0.0016 
                    hrs_wrk   1           0           .        .         . 
 
                                       Odds Ratio Estimates 
 
                                             Point       95% Confidence 
                        Effect            Estimate           Limits 
 
                        hrs_wrk 3 vs 1       1.666       0.689       4.028 
                        hrs_wrk 4 vs 1       2.482       1.413       4.359 
 
                               
 
Female 
                              Domain Analysis for domain sex_male=0 
 
                                    Type 3 Analysis of Effects 
 
                         Effect     F Value    Num DF    Den DF    Pr > F 
 
                         hrs_wrk      23.27         2      1000    <.0001 
 
 
                             Analysis of Maximum Likelihood Estimates 
 
                                               Standard 
                    Parameter      Estimate       Error    t Value    Pr > |t| 
 
                    Intercept       -4.2497      0.1660     -25.60      <.0001 
                    hrs_wrk   3      1.0045      0.4268       2.35      0.0188 
                    hrs_wrk   4      1.4381      0.2109       6.82      <.0001 
                    hrs_wrk   1           0           .        .         . 
 
                                       Odds Ratio Estimates 
 
                                             Point       95% Confidence 
                        Effect            Estimate           Limits 
 
                        hrs_wrk 3 vs 1       2.730       1.182       6.309 
                        hrs_wrk 4 vs 1       4.213       2.785       6.372 
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FINAL MODEL: MULTIVARIATE ANALYSIS 
 
Male 
 
                              Domain Analysis for domain sex_male=1 
 
                                    Type 3 Analysis of Effects 
 
                       Effect         F Value    Num DF    Den DF    Pr > F 
 
                       acos_age          4.16         4      1000    0.0024 
                       Mar_status        2.66         2      1000    0.0707 
                       prov_new3         3.09         4      1000    0.0152 
                       smk_typ           0.51         2      1000    0.6020 
                       hou_owned         8.94         1      1000    0.0029 
                       hou_rep           4.51         2      1000    0.0112 
                       diab_type12       1.62         1      1000    0.2027 
                       hrs_wrk           2.45         2      1000    0.0872 
 
 
                             Analysis of Maximum Likelihood Estimates 
 
                                                Standard 
                   Parameter        Estimate       Error    t Value    Pr > |t| 
 
                   Intercept         -5.5983      0.5458     -10.26      <.0001 
                   acos_age    1      0.0669      0.5266       0.13      0.8989 
                   acos_age    2      0.8336      0.3803       2.19      0.0286 
                   acos_age    3      1.4851      0.4339       3.42      0.0006 
                   acos_age    4      1.6077      0.4715       3.41      0.0007 
                   acos_age    0           0           .        .         . 
                   Mar_status  2      0.6671      0.3952       1.69      0.0917 
                   Mar_status  3      0.6744      0.3586       1.88      0.0603 
                   Mar_status  1           0           .        .         . 
                   prov_new3   1     -1.4764      0.4600      -3.21      0.0014 
                   prov_new3   3     -0.5403      0.4360      -1.24      0.2156 
                   prov_new3   4     -0.7223      0.4294      -1.68      0.0929 
                   prov_new3   5     -1.0303      0.4715      -2.18      0.0291 
                   prov_new3   2           0           .        .         . 
                   smk_typ     1      0.3080      0.3102       0.99      0.3211 
                   smk_typ     2      0.1013      0.5220       0.19      0.8462 
                   smk_typ     0           0           .        .         . 
                   hou_owned   0      0.8201      0.2743       2.99      0.0029 
                   hou_owned   1           0           .        .         . 
                   hou_rep     1      0.9786      0.3367       2.91      0.0037 
                   hou_rep     2      0.0832      0.3366       0.25      0.8048 
                   hou_rep     0           0           .        .         . 
                   diab_type12 1      0.4423      0.3469       1.27      0.2027 
                   diab_type12 0           0           .        .         . 
                   hrs_wrk     3      0.6628      0.4585       1.45      0.1486 
                   hrs_wrk     4      0.6353      0.3014       2.11      0.0353 
                   hrs_wrk     1           0           .        .         . 
 
                      NOTE: The degrees of freedom for the t tests is 1000. 
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Domain Analysis for domain sex_male=1 
 
                                       Odds Ratio Estimates 
 
                                               Point       95% Confidence 
                      Effect                Estimate           Limits 
 
                      acos_age    1 vs 0       1.069       0.380       3.005 
                      acos_age    2 vs 0       2.302       1.091       4.854 
                      acos_age    3 vs 0       4.415       1.885      10.346 
                      acos_age    4 vs 0       4.991       1.979      12.590 
                      Mar_status  2 vs 1       1.949       0.897       4.232 
                      Mar_status  3 vs 1       1.963       0.971       3.967 
                      prov_new3   1 vs 2       0.228       0.093       0.563 
                      prov_new3   3 vs 2       0.583       0.248       1.371 
                      prov_new3   4 vs 2       0.486       0.209       1.128 
                      prov_new3   5 vs 2       0.357       0.141       0.900 
                      smk_typ     1 vs 0       1.361       0.740       2.501 
                      smk_typ     2 vs 0       1.107       0.397       3.082 
                      hou_owned   0 vs 1       2.271       1.326       3.890 
                      hou_rep     1 vs 0       2.661       1.374       5.152 
                      hou_rep     2 vs 0       1.087       0.561       2.104 
                      diab_type12 1 vs 0       1.556       0.788       3.074 
                      hrs_wrk     3 vs 1       1.940       0.789       4.770 
                      hrs_wrk     4 vs 1       1.888       1.045       3.410 
 
 
Female 
 
                              Domain Analysis for domain sex_male=0 
 
                                    Type 3 Analysis of Effects 
 
                       Effect         F Value    Num DF    Den DF    Pr > F 
 
                       acos_age          3.23         4      1000    0.0120 
                       Mar_status        3.91         2      1000    0.0204 
                       prov_new3         7.84         4      1000    <.0001 
                       smk_typ           4.89         2      1000    0.0077 
                       hou_owned         6.36         1      1000    0.0118 
                       hou_rep           5.65         2      1000    0.0036 
                       diab_type12      13.39         1      1000    0.0003 
                       hrs_wrk          17.81         2      1000    <.0001 
 
 
                             Analysis of Maximum Likelihood Estimates 
 
                                                Standard 
                   Parameter        Estimate       Error    t Value    Pr > |t| 
 
                   Intercept         -4.8860      0.3647     -13.40      <.0001 
                   acos_age    1     -0.0671      0.3422      -0.20      0.8446 
                   acos_age    2      0.8705      0.3614       2.41      0.0162 
                   acos_age    3      0.1386      0.4651       0.30      0.7657 
                   acos_age    4     -0.0184      0.5419      -0.03      0.9729 
                   acos_age    0           0           .        .         . 
                   Mar_status  2      0.7892      0.3244       2.43      0.0151 
                   Mar_status  3      0.3781      0.2362       1.60      0.1098 
                   Mar_status  1           0           .        .         . 
                   prov_new3   1     -1.9082      0.3523      -5.42      <.0001 
                   prov_new3   3     -0.4814      0.3043      -1.58      0.1140 
                   prov_new3   4     -0.9215      0.2824      -3.26      0.0011 
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                   prov_new3   5     -1.0631      0.3310      -3.21      0.0014 
                   prov_new3   2           0           .        .         . 
                   smk_typ     1      0.6049      0.2346       2.58      0.0101 
                   smk_typ     2     -0.2161      0.4200      -0.51      0.6070 
                   smk_typ     0           0           .        .         . 
                   hou_owned   0      0.5319      0.2109       2.52      0.0118 
                   hou_owned   1           0           .        .         . 
                   hou_rep     1      0.9520      0.2831       3.36      0.0008 
                   hou_rep     2      0.2710      0.2204       1.23      0.2191 
                   hou_rep     0           0           .        .         . 
                   diab_type12 1      0.9007      0.2461       3.66      0.0003 
                   diab_type12 0           0           .        .         . 
                   hrs_wrk     3      1.1329      0.4460       2.54      0.0112 
                   hrs_wrk     4      1.3862      0.2360       5.87      <.0001 
                   hrs_wrk     1           0           .        .         .    
 
 
Domain Analysis for domain sex_male=0 
 
                                       Odds Ratio Estimates 
 
                                               Point       95% Confidence 
                      Effect                Estimate           Limits 
 
                      acos_age    1 vs 0       0.935       0.478       1.830 
                      acos_age    2 vs 0       2.388       1.175       4.853 
                      acos_age    3 vs 0       1.149       0.461       2.861 
                      acos_age    4 vs 0       0.982       0.339       2.844 
                      Mar_status  2 vs 1       2.202       1.165       4.161 
                      Mar_status  3 vs 1       1.459       0.918       2.320 
                      prov_new3   1 vs 2       0.148       0.074       0.296 
                      prov_new3   3 vs 2       0.618       0.340       1.123 
                      prov_new3   4 vs 2       0.398       0.229       0.693 
                      prov_new3   5 vs 2       0.345       0.180       0.661 
                      smk_typ     1 vs 0       1.831       1.155       2.902 
                      smk_typ     2 vs 0       0.806       0.353       1.837 
                      hou_owned   0 vs 1       1.702       1.125       2.575 
                      hou_rep     1 vs 0       2.591       1.486       4.516 
                      hou_rep     2 vs 0       1.311       0.851       2.021 
                      diab_type12 1 vs 0       2.461       1.518       3.990 
                      hrs_wrk     3 vs 1       3.105       1.294       7.449 
                      hrs_wrk     4 vs 1       3.999       2.517       6.355 
 
 
 
 
 
 
 
 
 
 
 
